{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:02:54Z","timestamp":1789722174288,"version":"4.0.1"},"reference-count":524,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Cutaneous and mucocutaneous dermatoses comprise a heterogeneous group of inflammatory, autoimmune, infectious, and immune-mediated diseases affecting epithelial barrier tissues, including skin and mucosal surfaces. Despite their diverse etiologies these conditions frequently share convergent pathogenic mechanisms characterized by epithelial barrier dysfunction and inflammation, contributing to a substantial global health burden. At the immunopathological level, these disorders frequently involve coordinated activation of innate immune sensing pathways followed by adaptive immune polarization driven by Th1, Th2, Th17 and CD8+ T cell\u2013associated responses. These pathways converge on shared intracellular signaling cascades, resulting in persistent cytokine production, chronic inflammation, and epithelial barrier disruption. Platelet-rich derivatives are autologous biologic therapies enriched in bioactive mediators with pleiotropic regenerative and immunomodulatory properties. Preclinical evidence indicates that these formulations modulate innate immune activation, promote macrophage polarization toward pro-regenerative phenotypes, influence dendritic cell maturation, and support regulatory T cell responses largely via modulation of NF-\u03baB, TLR, PI3K\/Akt, MAPK, and TGF-\u03b2\/SMAD-dependent pathways. In addition to immunomodulation, platelet-rich derivatives enhance tissue repair by promoting cell activation, angiogenesis, and extracellular matrix remodeling. They also contribute to epidermal barrier restoration and normalization of epithelial\u2013immune\u2013microbiome interactions. Despite the heterogeneity of underlying pathogenic molecular pathways, the multi-level effects of platelet-rich formulations provide a rationale for targeting shared downstream processes involved in tissue injury and disease progression. Clinical evidence, although heterogeneous and largely limited to small studies, suggests potential benefit in psoriasis, atopic dermatitis, lichen planus, lichen sclerosus, vitiligo, alopecia areata, and acne, with limited evidence in other mucocutaneous dermatoses associated with substantial primary or secondary inflammation. However, variability in pathophysiological landscapes, platelet-rich formulations and experimental designs limits definitive conclusions. Overall, platelet-derived therapies represent a promising adjunctive approach for restoring immune and epithelial homeostasis in inflammatory mucocutaneous disease, underscoring the need for methodologically standardized clinical and translational research and compliance with minimum reporting standards.<\/jats:p>","DOI":"10.3389\/fmed.2026.1901254","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:28:37Z","timestamp":1789720117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet-rich therapies in cutaneous and mucocutaneous disorders characterized by inflammatory tissue responses: mechanistic insights and clinical evidence"],"prefix":"10.3389","volume":"13","author":[{"given":"Eduardo","family":"Anitua","sequence":"first","affiliation":[{"name":"BTI Biotechnology Institute","place":["Vitoria, Spain"]},{"name":"University Institute for Regenerative Medicine and Oral Implantology, UIRMI (UPV\/EHU-Fundaci\u00f3n Eduardo Anitua)","place":["Vitoria, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tierno","sequence":"additional","affiliation":[{"name":"BTI Biotechnology Institute","place":["Vitoria, Spain"]},{"name":"University Institute for Regenerative Medicine and Oral Implantology, UIRMI (UPV\/EHU-Fundaci\u00f3n Eduardo Anitua)","place":["Vitoria, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hamdan","family":"Alkhraisat","sequence":"additional","affiliation":[{"name":"BTI Biotechnology Institute","place":["Vitoria, Spain"]},{"name":"University Institute for Regenerative Medicine and Oral Implantology, UIRMI (UPV\/EHU-Fundaci\u00f3n Eduardo Anitua)","place":["Vitoria, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cden.2019.08.009","article-title":"Mucocutaneous diseases","volume":"64","author":"Kuten-Shorrer","year":"2020","journal-title":"Dent Clin North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1600-0757.1998.tb00140.x","article-title":"Mucocutaneous disorders","volume":"18","author":"Scully","year":"2000","journal-title":"Periodontology."},{"key":"B3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/978-3-030-74720-6_57","article-title":"Dermatologic and mucocutaneous disorders","volume-title":"Geriatric Medicine: A Person Centered Evidence Based Approach.","author":"Zaladonis","year":"2024"},{"key":"B4","volume-title":"Fitzpatrick's Dermatology, Ninth Edition","author":"Kang","year":"2018"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.jid.2025.09.197","article-title":"191 the burden of mental health in inflammatory skin diseases: depression, anxiety, and quality of life in psoriasis, atopic dermatitis, and hidradenitis suppurativa","volume":"145","author":"Tunio","year":"2025","journal-title":"J Invest Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7861\/clinmedicine.9-6-592","article-title":"The burden of skin disease: quality of life, economic aspects and social issues","volume":"9","author":"Finlay","year":"2009","journal-title":"Clin Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s13671-017-0192-7","article-title":"Global burden of skin disease: inequities and innovations","volume":"6","author":"Seth","year":"2017","journal-title":"Curr Dermatol Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0244765","DOI":"10.1371\/journal.pone.0244765","article-title":"Psychosocial impact of skin diseases: a population-based study","volume":"15","author":"Yew","year":"2020","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B11","volume-title":"Dermatology E-Book","author":"Bolognia","year":"2017"},{"key":"B12","volume-title":"Andrews' Diseases of the Skin: Clinical Dermatology.","author":"James","year":"2015"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0399","article-title":"The diagnosis and treatment of autoimmune blistering skin diseases","author":"Schmidt","year":"2011","journal-title":"Deutsches Arzteblatt Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1403798","DOI":"10.3389\/fimmu.2024.1403798","article-title":"Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea","volume":"15","author":"Tu","year":"2024","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1126\/science.1260144","article-title":"Dialogue between skin microbiota and immunity","volume":"346","author":"Belkaid","year":"2014","journal-title":"Science."},{"key":"B18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?","volume":"21","author":"Akdis","year":"2021","journal-title":"Nat Rev Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1002\/1873-3468.70113","article-title":"The epithelial barrier theory proposes a comprehensive explanation for the origins of allergic and other chronic non-communicable diseases","volume":"599","author":"Zeyneloglu","year":"2025","journal-title":"FEBS Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"101846","DOI":"10.1016\/j.smim.2023.101846","article-title":"The epithelial barrier: the gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions","volume":"70","author":"Yazici","year":"2023","journal-title":"Semin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1001397","DOI":"10.1371\/journal.pbio.1001397","article-title":"Inside the mucosal immune system","volume":"10","author":"McGhee","year":"2012","journal-title":"PLoS Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e70053","DOI":"10.1002\/cti2.70053","article-title":"Skin immunity and inflammation: cellular interactions and communication","volume":"14","author":"Narayanan","year":"2025","journal-title":"Clin Transl Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3390\/ijms20081811","article-title":"The dynamics of the skin's immune system","volume":"20","author":"Nguyen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","article-title":"Mucosal immune response in biology, disease prevention and treatment","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct Target Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.4110\/in.2024.24.e33","article-title":"Th pathways in immune-mediated skin disorders: a guide for strategic treatment decisions","volume":"24","author":"Speeckaert","year":"2024","journal-title":"Immune Netw."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.jid.2024.06.1280","article-title":"The central roles of keratinocytes in coordinating skin immunity","volume":"144","author":"Simmons","year":"2024","journal-title":"J Invest Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e86937","DOI":"10.7759\/cureus.86937","article-title":"Skin barrier dysfunction in chronic dermatoses: from pathophysiology to emerging therapeutic strategies","volume":"17","author":"Espinoza Urzua","year":"2025","journal-title":"Cureus."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.3390\/ijms22179383","article-title":"Synopsis of barrier function of skin and oral mucosa-volume 1","volume":"22","author":"Wertz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.3390\/ijms241813690","article-title":"Synopsis of barrier function of skin and mucosa-volume 2","volume":"24","author":"Wertz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nri3228","article-title":"Epithelial antimicrobial defence of the skin and intestine","volume":"12","author":"Gallo","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/cod.13959","article-title":"Dysregulation of the epithelial barrier by environmental and other exogenous factors","volume":"85","author":"Mitamura","year":"2021","journal-title":"Contact Dermatitis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","article-title":"Platelet-rich plasma: evidence to support its use","volume":"62","author":"Marx","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e66734","DOI":"10.7759\/cureus.66734","article-title":"Platelet-rich plasma in aesthetic dermatology: current evidence and future directions","volume":"16","author":"Asubiaro","year":"2024","journal-title":"Cureus."},{"key":"B37","first-page":"1","article-title":"Platelet-Rich plasma (PRP): current applications in dermatology","volume":"24","author":"Emer","year":"2019","journal-title":"Skin Therapy Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/biomedicines12010007","article-title":"Platelet-rich plasma (PRP) in dermatology: cellular and molecular mechanisms of action","volume":"12","author":"Vladulescu","year":"2023","journal-title":"Biomedicines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/jocd.12167","article-title":"Systematic review of the use of platelet-rich plasma in aesthetic dermatology","volume":"14","author":"Leo","year":"2015","journal-title":"J Cosmet Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1515\/med-2016-0048","article-title":"Platelet rich plasma: a short overview of certain bioactive components","volume":"11","author":"Pavlovic","year":"2016","journal-title":"Open Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12903-025-06189-7","article-title":"Use of platelet-rich plasma (PRP) and injectable platelet-rich fibrin (i-PRF) in oral lichen planus treatment: a systematic review of randomized controlled trials","volume":"25","author":"Niemczyk","year":"2025","journal-title":"BMC Oral Health."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.arthro.2021.07.003","article-title":"Platelet-rich plasma: fundamentals and clinical applications","volume":"37","author":"Sheean","year":"2021","journal-title":"Arthroscopy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00296-024-05776-1","article-title":"Use of platelet-rich plasma in rheumatic diseases","volume":"45","author":"Yessirkepov","year":"2024","journal-title":"Rheumatol Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3852898","DOI":"10.21203\/rs.3.rs-1423315\/v1","article-title":"Variability in platelet-rich plasma preparations used in regenerative medicine: a comparative analysis","volume":"2022","author":"Tey","year":"2022","journal-title":"Stem Cells Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.3390\/ijms21165702","article-title":"Systematic review-the potential implications of different platelet-rich plasma (PRP) concentrations in regenerative medicine for tissue repair","volume":"21","author":"Gentile","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e47176","DOI":"10.7759\/cureus.47176","article-title":"Current status and advancements in platelet-rich plasma therapy","volume":"15","author":"Pretorius","year":"2023","journal-title":"Cureus."},{"key":"B48","doi-asserted-by":"publisher","first-page":"26348535241277625","DOI":"10.1177\/26348535241277625","article-title":"Complexity of platelet-rich plasma: mechanism of action, growth factor utilization and variation in preparation","volume":"18","author":"Pineda-Cortel","year":"2024","journal-title":"Plasmatology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.18168","article-title":"Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe","volume":"36","author":"Augustin","year":"2022","journal-title":"J Euro Acad Dermatol Venereol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2340\/00015555-3102","article-title":"Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries","volume":"99","author":"Zink","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"A606","DOI":"10.1016\/j.jval.2014.08.2112","article-title":"Costs of psoriasis in Europe. A systematic review of the literature","volume":"17","author":"Obradors","year":"2014","journal-title":"Value Health."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1007\/s00784-021-04353-1","article-title":"Cost of illness of oral lichen planus: a multicenter university hospital-based outpatient observational study","volume":"26","author":"Lajolo","year":"2022","journal-title":"Clin Oral Investig"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3201\/eid1011.040367","article-title":"Women and autoimmune diseases","volume":"10","author":"Fairweather","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"adv42441","DOI":"10.2340\/actadv.v104.42441","article-title":"Sex differences in dermatology life quality index (DLQI) among patients with psoriasis","volume":"104","author":"Jensen","year":"2024","journal-title":"Acta Dermato Venereol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","article-title":"Global skin disease morbidity and mortality: an update from the global burden of disease study 2013","volume":"153","author":"Karimkhani","year":"2017","journal-title":"JAMA Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/sj.jid.5701239","article-title":"Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life","volume":"128","author":"Nikolovski","year":"2008","journal-title":"J Invest Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.3928\/19382359-20240205-02","article-title":"Atopic dermatitis in children","volume":"53","author":"Kruse","year":"2024","journal-title":"Pediatr Ann."},{"key":"B58","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/jdv.19580","article-title":"Gender differences in adult atopic dermatitis and clinical implication: results from a nationwide multicentre study","volume":"38","author":"Marani","year":"2024","journal-title":"J Euro Acad Dermatol Venereol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.08.002","article-title":"Dermatologic health disparities","author":"Buster","year":"2012","journal-title":"Dermatol Clin"},{"key":"B60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdin.2020.07.001","article-title":"Burden of skin disease and associated socioeconomic status in Europe: an ecologic study from the global burden of disease study 2017","volume":"1","author":"Chu","year":"2020","journal-title":"JAAD Int."},{"key":"B61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2340\/00015555-3082","article-title":"Socioeconomic status and the prevalence of skin and atopic diseases in five European countries","volume":"99","author":"Ofenloch","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e34594","DOI":"10.1371\/journal.pone.0034594","article-title":"Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis","volume":"7","author":"Swindell","year":"2012","journal-title":"PLoS ONE."},{"key":"B64","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.3390\/ijms222312793","article-title":"The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications","volume":"22","author":"Singh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.3390\/ijms21197041","article-title":"The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic","volume":"21","author":"Woo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"108397","DOI":"10.1016\/j.clim.2020.108397","article-title":"Comorbidities associated with psoriatic arthritis: review and update","volume":"214","author":"Perez-Chada","year":"2020","journal-title":"Clin Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/ced\/llaf233","article-title":"Epidemiology of atopic dermatitis: a global worldwide study","volume":"50","author":"Skayem","year":"2025","journal-title":"Clin Exp Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bjd\/ljad339","article-title":"Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study","volume":"190","author":"Tian","year":"2023","journal-title":"Br J Dermatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"adv00161","DOI":"10.2340\/00015555-3511","article-title":"Counting the burden: atopic dermatitis and health-related quality of life","volume":"100","author":"Ali","year":"2020","journal-title":"Acta Dermato Venereol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","article-title":"The burden of atopic dermatitis: summary of a report for the national eczema association","volume":"137","author":"Drucker","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jid.2024.03.003","article-title":"Halting the vicious cycle of atopic dermatitis: empowered by scientific understanding","volume":"144","author":"Brown","year":"2024","journal-title":"J Invest Dermatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaci.2022.12.002","article-title":"Comorbidities of atopic dermatitis-what does the evidence say?","volume":"151","author":"Thyssen","year":"2023","journal-title":"J Allergy Clin Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet."},{"key":"B77","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/jamadermatol.2024.1987","article-title":"The global prevalence of seborrheic dermatitis: a systematic review and meta-analysis","volume":"160","author":"Polaskey","year":"2024","journal-title":"JAMA Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/DER.0b013e318260d5a0","article-title":"Nummular eczema and contact allergy: a retrospective study","volume":"23","author":"Bonamonte","year":"2012","journal-title":"Dermatitis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.abd.2023.01.004","article-title":"Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study","volume":"99","author":"Cavalcante","year":"2024","journal-title":"An Bras Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.1002\/der2.70043","article-title":"Radiation dermatitis: a comparative review of prevention and management","volume":"6","author":"Chaudry","year":"2025","journal-title":"Dermatol Rev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.12788\/j.suponc.0009","article-title":"Characterization of skin reactions and pain reported by patients receiving radiation therapy for cancer at different sites","volume":"11","author":"Gewandter","year":"2013","journal-title":"J Support Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/odi.13323","article-title":"Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis","volume":"27","author":"Gonz\u00e1lez-Moles","year":"2021","journal-title":"Oral Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jaad.2024.09.081","article-title":"Prevalence and treatment patterns of lichen planus","volume":"92","author":"Pelet Del Toro","year":"2025","journal-title":"J Am Acad Dermatol."},{"key":"B84","first-page":"53","article-title":"Diagnosis and treatment of lichen planus","volume":"84","author":"Usatine","year":"2011","journal-title":"Am Fam Physician."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.4317\/jced.55145","article-title":"Rodr\u00edguez-de Rivera-Campillo ME, Otero-Rey EM, Estrugo-Devesa A, Jan\u00e9-Salas E, L\u00f3pez-L\u00f3pez J. Oral lichen planus and its relationship with systemic diseases. A review of evidence","volume":"10","author":"Cassol-Spanemberg","year":"2018","journal-title":"J Clin Exp Dent"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1106318","DOI":"10.3389\/fmed.2023.1106318","article-title":"Lichen sclerosus: the 2023 update","volume":"10","author":"De Luca","year":"2023","journal-title":"Front Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.adengl.2011.05.004","article-title":"Lichen sclerosus and squamous cell carcinoma","volume":"103","author":"Guti\u00e9rrez-Pascual","year":"2012","journal-title":"Actas Dermosifiliogr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/CLEP.S459600","article-title":"Epidemiology of invasive candidiasis","volume":"16","author":"Bays","year":"2024","journal-title":"Clin Epidemiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/sextrans-2024-056307","article-title":"Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses","volume":"101","author":"Harfouche","year":"2025","journal-title":"Sex Transm Infect."},{"key":"B90","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s15010-022-01888-7","article-title":"Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr","volume":"51","author":"Reda","year":"2023","journal-title":"Infection."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e0136789","DOI":"10.1371\/journal.pone.0136789","article-title":"The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma","volume":"10","author":"Bowen","year":"2015","journal-title":"PLoS ONE."},{"key":"B92","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.humpath.2023.07.003","article-title":"Emerging infectious diseases of the skin: a review of clinical and histologic findings","volume":"140","author":"McMahon","year":"2023","journal-title":"Hum Pathol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/medicina57090895","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz","year":"2021","journal-title":"Medicina"},{"key":"B94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ph19010021","article-title":"Real-world data on severe cutaneous adverse reactions to drugs","volume":"19","author":"Zyryanov","year":"2026","journal-title":"Pharmaceuticals."},{"key":"B95","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43556-025-00272-9","article-title":"Autoimmune bullous diseases: pathogenesis and clinical management","volume":"6","author":"Feng","year":"2025","journal-title":"Mol Biomed."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1111\/jdv.17465","article-title":"The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study","volume":"35","author":"Kridin","year":"2021","journal-title":"J Euro Acad Dermatol Venereol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/jdv.20156","article-title":"Psychosocial burden of autoimmune blistering diseases: a comprehensive survey study","volume":"39","author":"White","year":"2025","journal-title":"J Euro Acad Dermatol Venereol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s13555-025-01444-9","article-title":"A narrative review of pemphigoid diseases: bridging associations, comorbidities, and management","volume":"15","author":"Myers","year":"2025","journal-title":"Dermatol Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1159351","DOI":"10.3389\/fimmu.2023.1159351","article-title":"Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid","volume":"14","author":"Rosi-Schumacher","year":"2023","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"897987","DOI":"10.3389\/fmed.2022.897987","article-title":"The burden of living with cutaneous lupus erythematosus","volume":"9","author":"Drenkard","year":"2022","journal-title":"Front Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamadermatol.2018.0616","article-title":"Autoimmune diseases in patients with cutaneous lupus erythematosus","volume":"154","author":"Kunzler","year":"2018","journal-title":"JAMA Dermatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.mayocp.2022.06.022","article-title":"Epidemiology of cutaneous lupus erythematosus among adults over four decades (1976\u20132018): a lupus midwest network (LUMEN) study","volume":"97","author":"Hocaoglu","year":"2022","journal-title":"Mayo Clin Proc."},{"key":"B103","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1097\/JS9.0000000000004028","article-title":"Skin and subcutaneous disease burden, 1990\u20132021: a GBD review","volume":"112","author":"Li","year":"2026","journal-title":"Int J Surg."},{"key":"B104","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2014.530","article-title":"The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries","volume":"135","author":"Dalgard","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1620940","DOI":"10.3389\/fmed.2025.1620940","article-title":"Shame and disgust in patients with inflammatory skin diseases: a systematic review of psychological correlates and psychotherapeutic approaches","volume":"12","author":"Fink-Lamotte","year":"2025","journal-title":"Front Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jdin.2024.11.006","article-title":"Evaluating the psychosocial burden and unmet needs for health care access among older adults with inflammatory skin disease","volume":"18","author":"Roberts","year":"2025","journal-title":"JAAD Int."},{"key":"B107","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/cosmetics12030106","article-title":"The epidemiology of acne in the current era: trends and clinical implications","volume":"12","author":"Gugulu\u015f","year":"2025","journal-title":"Cosmetics."},{"key":"B108","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/bjd.16481","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e16678","DOI":"10.1111\/jocd.16678","article-title":"Stigmatization and psychosocial burden in acne patients","volume":"24","author":"Tunca","year":"2025","journal-title":"J Cosmet Dermatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamadermatol.2025.2373","article-title":"Prevalence of hidradenitis suppurativa: a meta-analysis of global hidradenitis suppurativa atlas studies","volume":"161","author":"Bouazzi","year":"2025","journal-title":"JAMA Dermatol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/ijerph18136709","article-title":"The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis","volume":"18","author":"Montero-Vilchez","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","article-title":"Estimating the burden of vitiligo: a systematic review and modelling study","volume":"9","author":"Akl","year":"2024","journal-title":"Lancet Public health."},{"key":"B113","doi-asserted-by":"publisher","first-page":"25869","DOI":"10.1038\/s41598-025-07224-x","article-title":"Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data","volume":"15","author":"Ding","year":"2025","journal-title":"Sci Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s13555-023-01001-2","article-title":"Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis","volume":"13","author":"Ezzedine","year":"2023","journal-title":"Dermatol Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40257-023-00805-4","article-title":"Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis","volume":"24","author":"Ly","year":"2023","journal-title":"Am J Clin Dermatol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O'Shea","year":"2015","journal-title":"Annu Rev Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"104541","DOI":"10.1016\/j.ad.2025.104541","article-title":"Overlap between psoriasis and atopic dermatitis: therapeutic approach","volume":"117","author":"Tous-Romero","year":"2026","journal-title":"Actas Dermo Sifiliogr\u00e1ficas"},{"key":"B119","doi-asserted-by":"publisher","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72","author":"O'Shea","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"100001","DOI":"10.1016\/j.xjidi.2021.100001","article-title":"Hidradenitis suppurativa: host-microbe and immune pathogenesis underlie important future directions","volume":"1","author":"Jiang","year":"2021","journal-title":"JID Innov."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1705588","DOI":"10.3389\/fimmu.2025.1595493","article-title":"Advances in the pathogenesis of rosacea","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/1346-8138.70077","article-title":"Updates in pathogenesis of pemphigus vulgaris","volume":"53","author":"Yang","year":"2026","journal-title":"J Dermatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"10152","DOI":"10.3390\/ijms251810152","article-title":"Pathogenesis of inflammation in skin disease: from molecular mechanisms to pathology","volume":"25","author":"Shirley","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B125","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","article-title":"Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?","volume":"48","author":"Guttman-Yassky","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2021.07.014","article-title":"Innate immune sensing by epithelial barriers","volume":"73","author":"Constant","year":"2021","journal-title":"Curr Opin Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1361005","DOI":"10.3389\/fimmu.2024.1361005","article-title":"Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches","volume":"15","author":"Afshari","year":"2024","journal-title":"Front Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.immuni.2019.08.005","article-title":"Inflammasomes: Threat-assessment organelles of the innate immune system","volume":"51","author":"Evavold","year":"2019","journal-title":"Immunity."},{"key":"B131","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.molmed.2018.01.004","article-title":"Inflammasome, inflammation, and tissue homeostasis","volume":"24","author":"Rathinam","year":"2018","journal-title":"Trends Mol Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","article-title":"Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"169","author":"Kim","year":"2002","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/jid.2013.309","article-title":"Propionibacterium acnes Induces IL-1\u03b2 secretion via the NLRP3 inflammasome in human monocytes","volume":"134","author":"Qin","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12321.x","article-title":"Inflammatory events are involved in acne lesion initiation","volume":"121","author":"Jeremy","year":"2003","journal-title":"J Invest Dermatol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3389\/fimmu.2019.01764","article-title":"Adaptive and innate immunity in psoriasis and other inflammatory disorders","volume":"10","author":"Sch\u00f6n","year":"2019","journal-title":"Front Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/jcm12083043","article-title":"Potential role of innate lymphoid cells in the pathogenesis and treatment of skin diseases","volume":"12","author":"Borgia","year":"2023","journal-title":"J Clin Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.archoralbio.2013.12.010","article-title":"Gene expression based evidence of innate immune response activation in the epithelium with oral lichen planus","volume":"59","author":"Adami","year":"2014","journal-title":"Arch Oral Biol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12016-010-8227-x","article-title":"Innate immunity in atopic dermatitis","volume":"41","author":"Wollenberg","year":"2011","journal-title":"Clin Rev Allergy Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/all.15104","article-title":"T-cell subsets in the skin and their role in inflammatory skin disorders","volume":"77","author":"Kortekaas Krohn","year":"2022","journal-title":"Allergy."},{"key":"B143","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/S0190-9622(03)01134-4","article-title":"The immunology of psoriasis and biologic immunotherapy","volume":"49","author":"Mehlis","year":"2003","journal-title":"J Am Acad Dermatol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.4110\/in.2022.22.e7","article-title":"Immunopathology and immunotherapy of inflammatory skin diseases","volume":"22","author":"Song","year":"2022","journal-title":"Immune Netw."},{"key":"B145","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e24137","DOI":"10.4161\/jkst.24137","article-title":"The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis","volume":"2","author":"Bao","year":"2013","journal-title":"Jak-stat."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/eji.201646680","article-title":"Targeting JAK\/STAT signalling in inflammatory skin diseases with small molecule inhibitors","volume":"47","author":"Welsch","year":"2017","journal-title":"Eur J Immunol."},{"key":"B148","first-page":"S44","article-title":"Signalling in inflammatory skin disease by AP-1 (Fos\/Jun)","volume":"33","author":"Ulu\u00e7kan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1428209","DOI":"10.3389\/fimmu.2024.1428209","article-title":"Editorial: epithelial immune microenvironment and inflammatory skin diseases","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/jdv.15973","article-title":"Neuroimmune interactions in chronic itch of atopic dermatitis","volume":"34","author":"Yosipovitch","year":"2020","journal-title":"J Europ Acad Dermatol Venereol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4168\/aair.2018.10.3.207","article-title":"Significance of skin barrier dysfunction in atopic dermatitis","volume":"10","author":"Kim","year":"2018","journal-title":"Allergy Asthma Immunol Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine."},{"key":"B153","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1080\/1744666X.2022.2011720","article-title":"Cytokine alterations in psoriasis: an updated review","volume":"17","author":"Seyedmirzaei","year":"2021","journal-title":"Expert Rev Clin Immunol."},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12876121","article-title":"Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis","author":"Krueger","year":"1990","journal-title":"J Invest Dermatol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.35702\/Derm.10016","article-title":"Dermatitis; types, causes, symptoms and management: a review","volume":"4","author":"Ali","year":"2024","journal-title":"Dermis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10787-025-01642-z","article-title":"Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights","volume":"33","author":"Abdel-Mageed","year":"2025","journal-title":"Inflammopharmacology."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/medicina60081376","article-title":"Restoration of skin barrier abnormalities with IL4\/13 inhibitors and jak inhibitors in atopic dermatitis: a systematic review","volume":"60","author":"Chatzigeorgiou","year":"2024","journal-title":"Medicina."},{"key":"B159","doi-asserted-by":"publisher","first-page":"97","DOI":"10.22034\/IJI.2019.80253","article-title":"Pathogenesis of atopic dermatitis: current paradigm","volume":"16","author":"Furue","year":"2019","journal-title":"Iran J Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.anai.2023.09.009","article-title":"Filaggrin and beyond: new insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives","volume":"132","author":"Stefanovic","year":"2024","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/09546634.2017.1290205","article-title":"Interleukin-31 pathway and its role in atopic dermatitis: a systematic review","volume":"28","author":"Saleem","year":"2017","journal-title":"J Dermatolog Treat."},{"key":"B163","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1346-8138.2001.tb00124.x","article-title":"Reduction of serum interleukin-5 levels reflect clinical improvement in patients with atopic dermatitis","volume":"28","author":"Kondo","year":"2001","journal-title":"J Dermatol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.4049\/jimmunol.178.9.5571","article-title":"Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions","volume":"178","author":"Hennino","year":"2007","journal-title":"J Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"100014","DOI":"10.1016\/j.xjidi.2021.100014","article-title":"T-cell adhesion in healthy and inflamed skin","volume":"1","author":"Moreau","year":"2021","journal-title":"JID Innova."},{"key":"B166","doi-asserted-by":"publisher","first-page":"e1006196","DOI":"10.1371\/journal.ppat.1006196","article-title":"CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1\u03b2 production","volume":"13","author":"Novais","year":"2017","journal-title":"PLoS Pathog."},{"key":"B167","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mehy.2016.04.042","article-title":"Targeting the IFN-\u03b3\/CXCL10 pathway in lichen planus","volume":"92","author":"Di","year":"2016","journal-title":"Med Hypotheses."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/odi.14142","article-title":"Immune mechanisms in oral lichen planus","volume":"29","author":"El-Howati","year":"2023","journal-title":"Oral Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0002-9440(10)63649-8","article-title":"Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES\/CCL5 and IP-10\/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism","volume":"163","author":"Iijima","year":"2003","journal-title":"Am J Pathol."},{"key":"B170","volume-title":"Lichen Planopilaris","author":"Lepe","year":"2026"},{"key":"B171","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40257-024-00912-w","article-title":"Frontal fibrosing alopecia: an update","volume":"26","author":"Messenger","year":"2025","journal-title":"Am J Clin Dermatol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"e2250281","DOI":"10.1002\/eji.202250281","article-title":"The IFN-\u03b3-CXCL9\/CXCL10-CXCR3 axis in vitiligo: pathological mechanism and treatment","volume":"54","author":"Liu","year":"2024","journal-title":"Eur J Immunol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8(+) T cells in vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"13","author":"Speeckaert","year":"2024","journal-title":"J Clin Med"},{"key":"B175","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/s41598-025-86134-4","article-title":"Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS","volume":"15","author":"Dong","year":"2025","journal-title":"Sci Rep."},{"key":"B176","volume-title":"Lichen Sclerosus.","author":"Chamli","year":"2026"},{"key":"B177","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jdv.70186","article-title":"Update on cutaneous lupus erythematosus pathogenesis, diagnosis and management","volume":"40","author":"Chasset","year":"2026","journal-title":"J Euro Acad Dermatol Venereol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.clindermatol.2022.02.009","article-title":"The genetics of pediatric cutaneous autoimmunity: the sister diseases vitiligo and alopecia areata","volume":"40","author":"Silverberg","year":"2022","journal-title":"Clin Dermatol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/s41590-023-01547-5","article-title":"A virtual memory CD8(+) T cell-originated subset causes alopecia areata through innate-like cytotoxicity","volume":"24","author":"Seok","year":"2023","journal-title":"Nat Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e78298","DOI":"10.7759\/cureus.78298","article-title":"Alopecia areata: understanding the pathophysiology and advancements in treatment modalities","volume":"17","author":"Abarca","year":"2025","journal-title":"Cureus."},{"key":"B182","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp Dermatol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"e70182","DOI":"10.1002\/mco2.70182","article-title":"Alopecia areata: pathogenesis, diagnosis, and therapies","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm."},{"key":"B184","doi-asserted-by":"publisher","first-page":"d343","DOI":"10.2741\/A196","article-title":"Human skin basement membrane in health and in autoimmune diseases","volume":"2","author":"Chan","year":"1997","journal-title":"Front Biosci."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3389\/fimmu.2019.01089","article-title":"Skin barrier and autoimmunity-mechanisms and novel therapeutic approaches for autoimmune blistering diseases of the skin","volume":"10","author":"Stevens","year":"2019","journal-title":"Front Immunol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/medicina57101080","article-title":"An updated review of pemphigus diseases","volume":"57","author":"Malik","year":"2021","journal-title":"Medicina"},{"key":"B188","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41572-025-00595-5","article-title":"Bullous pemphigoid","volume":"11","author":"Akbarialiabad","year":"2025","journal-title":"Nat Rev Dis Prim."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.42983","article-title":"Understanding the role of type I interferons in cutaneous lupus and dermatomyositis: toward better therapeutics","volume":"77","author":"Hile","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: diagnosis and treatment. Best practice & research","volume":"27","author":"Okon","year":"2013","journal-title":"Clin Rheumatol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3390\/jcm13082419","article-title":"The spectrum of cutaneous manifestations in lupus erythematosus: a comprehensive review","volume":"13","author":"Fija\u0142kowska","year":"2024","journal-title":"J Clin Med"},{"key":"B192","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamadermatol.2013.5079","article-title":"Morphea (localized scleroderma)","volume":"149","author":"Fett","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.09.006","article-title":"Small vessel vasculitis of the skin","author":"Micheletti","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"B195","doi-asserted-by":"publisher","first-page":"102493","DOI":"10.1016\/j.coi.2024.102493","article-title":"Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases","volume":"91","author":"Ogulur","year":"2024","journal-title":"Curr Opin Immunol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.alit.2021.11.006","article-title":"Skin barrier defects in atopic dermatitis: from old idea to new opportunity","volume":"71","author":"Yoshida","year":"2022","journal-title":"Allergol Int."},{"key":"B197","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s13671-018-0232-y","article-title":"Skin barrier function and atopic dermatitis","volume":"7","author":"Rerknimitr","year":"2018","journal-title":"Curr Dermatol Rep."},{"key":"B198","doi-asserted-by":"publisher","first-page":"10841","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B199","doi-asserted-by":"publisher","first-page":"e0257356","DOI":"10.1371\/journal.pone.0257356","article-title":"Gene signatures associated with barrier dysfunction and infection in oral lichen planus identified by analysis of transcriptomic data","volume":"16","author":"Vo","year":"2021","journal-title":"PLoS ONE."},{"key":"B200","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2340\/00015555-2533","article-title":"Alterations in factors involved in differentiation and barrier function in the epithelium in oral and genital lichen planus","volume":"97","author":"Danielsson","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","article-title":"Hidradenitis suppurativa","volume":"405","author":"Sabat","year":"2025","journal-title":"Lancet."},{"key":"B202","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"B203","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/1346-8138.70191","article-title":"Dysbiosis in the pathogenesis of atopic dermatitis","volume":"53","author":"Okamoto","year":"2026","journal-title":"J Dermatol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship","volume":"26","author":"Geoghegan","year":"2018","journal-title":"Trends Microbiol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"567090","DOI":"10.3389\/fmicb.2020.567090","article-title":"Colonization with staphylococcus aureus in atopic dermatitis patients: attempts to reveal the unknown","volume":"11","author":"Ogonowska","year":"2020","journal-title":"Front Microbiol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1714515","DOI":"10.3389\/fimmu.2026.1714515","article-title":"Psoriasis: microbiome dysbiosis and pathogenic mechanisms","volume":"17","author":"Wang","year":"2026","journal-title":"Front Immunol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/medicina61091632","article-title":"Genital lichen sclerosus-the role of the vulvar microbiome","volume":"61","author":"Jerkovic Gulin","year":"2025","journal-title":"Medicina"},{"key":"B208","doi-asserted-by":"publisher","first-page":"e0267424","DOI":"10.1128\/spectrum.02674-24","article-title":"Cutaneous dysbiosis in girls with vulvar lichen sclerosus","volume":"13","author":"Sun","year":"2025","journal-title":"Microbiol Spect."},{"key":"B209","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12866-020-01733-7","article-title":"Dysbiosis of saliva microbiome in patients with oral lichen planus","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Microbiol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/jpm14040386","article-title":"Role of oral microbiota dysbiosis in the development and progression of oral lichen planus","volume":"14","author":"Lavoro","year":"2024","journal-title":"J Personal Med"},{"key":"B211","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13555-023-01079-8","article-title":"The microbiome and acne: perspectives for treatment","volume":"14","author":"Dessinioti","year":"2024","journal-title":"Dermatol Ther."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/odi.70207","article-title":"Oral microbial dysbiosis and pathogenic functional shifts in mucosa-dominant pemphigus vulgaris and low-risk mucous membrane pemphigoid","volume":"32","author":"Ye","year":"2026","journal-title":"Oral Dis."},{"key":"B213","doi-asserted-by":"publisher","first-page":"100363","DOI":"10.1016\/j.xjidi.2025.100363","article-title":"Cutaneous and gut dysbiosis in alopecia areata: a review","volume":"5","author":"Burma","year":"2025","journal-title":"JID Innov."},{"key":"B214","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s13555-024-01281-2","article-title":"Association between scalp microbiota imbalance, disease severity, and systemic inflammatory markers in alopecia areata","volume":"14","author":"G\u00f3mez-Arias","year":"2024","journal-title":"Dermatol Ther."},{"key":"B215","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4103\/ijd.ijd_623_21","article-title":"Hidradenitis suppurativa: consequences of microbiome dysbiosis on immune dysregulation and disease severity","volume":"67","author":"Chung","year":"2022","journal-title":"Indian J Dermatol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"9542","DOI":"10.3390\/ijms26199542","article-title":"Unveiling the microbiome's role in hidradenitis suppurativa: a comprehensive review of pathogenetic mechanisms","volume":"26","author":"Queir\u00f3s","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B217","doi-asserted-by":"publisher","first-page":"001449","DOI":"10.1099\/mgen.0.001449","article-title":"Insights into microbial dysbiosis and Cutibacterium acnes CAMP factor interactions in acne vulgaris","volume":"11","author":"Chen","year":"2025","journal-title":"Microb Genom"},{"key":"B218","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.micinf.2010.03.013","article-title":"Host responses to Candida albicans: Th17 cells and mucosal candidiasis","volume":"12","author":"Conti","year":"2010","journal-title":"Microb Infect."},{"key":"B219","doi-asserted-by":"publisher","first-page":"e0193721","DOI":"10.1128\/mBio.01937-21","article-title":"Mucosal bacteria modulate candida albicans virulence in oropharyngeal candidiasis","volume":"12","author":"Bertolini","year":"2021","journal-title":"MBio."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","article-title":"Itch: from mechanism to (novel) therapeutic approaches","volume":"142","author":"Yosipovitch","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/sj.jid.5700231","article-title":"Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus","volume":"126","author":"Steinhoff","year":"2006","journal-title":"J Invest Dermatol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jocd.12204","article-title":"Relationship between transient receptor potential vanilloid-1 expression and the intensity of sensitive skin symptoms","volume":"15","author":"Ehnis-P\u00e9rez","year":"2016","journal-title":"J Cosmet Dermatol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.clindermatol.2020.06.016","article-title":"Diagnosis and management of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"38","author":"Noe","year":"2020","journal-title":"Clin Dermatol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40257-015-0158-0","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: an update","volume":"16","author":"Dodiuk-Gad","year":"2015","journal-title":"Am J Clin Dermatol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-3-319-74588-6_195","article-title":"Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): immunologic reactions: oncologic","volume":"9","author":"Zimmerman","year":"2019","journal-title":"Crit Care"},{"key":"B228","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2741\/4613","article-title":"The biology of the platelet with special reference to inflammation, wound healing and immunity","volume":"23","author":"Nurden","year":"2018","journal-title":"Front Biosci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells: bridging inflammation and cardiovascular disease","volume":"100","author":"von Hundelshausen","year":"2007","journal-title":"Circ Res."},{"key":"B230","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/jfb11020031","article-title":"Autologous matrix of platelet-rich fibrin in wound care settings: a systematic review of randomized clinical trials","volume":"11","author":"de Carvalho","year":"2020","journal-title":"J Funct Biomat"},{"key":"B231","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1902\/jop.2007.060302","article-title":"Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties","volume":"78","author":"El-Sharkawy","year":"2007","journal-title":"J Periodontol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/jth.12730","article-title":"Platelets in inflammation and immunity","volume":"12","author":"Herter","year":"2014","journal-title":"J Thromb Haemost."},{"key":"B233","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1182\/blood.V95.4.1158.004k31_1158_1166","article-title":"The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages","volume":"95","author":"Scheuerer","year":"2000","journal-title":"Blood."},{"key":"B234","doi-asserted-by":"publisher","first-page":"672395","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators Inflamm"},{"key":"B235","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Freedman J. Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jcp.22274","article-title":"Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-\u03baB inhibition via HGF","volume":"225","author":"Bendinelli","year":"2010","journal-title":"J Cell Physiol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","article-title":"Platelet-rich plasma for managing pain and inflammation in osteoarthritis","volume":"9","author":"Andia","year":"2013","journal-title":"Nat Rev Rheumatol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1055\/s-0039-1685495","article-title":"The role of human platelet preparation for toll-like receptors 2 and 4 related platelet responsiveness","volume":"3","author":"Koessler","year":"2019","journal-title":"TH Open."},{"key":"B240","doi-asserted-by":"publisher","first-page":"108962","DOI":"10.1016\/j.intimp.2022.108962","article-title":"Platelet-rich plasma-derived exosomes attenuate intervertebral disc degeneration by promoting NLRP3 autophagic degradation in macrophages","volume":"110","author":"Qian","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/jth.15172","article-title":"Platelet-conditioned media induces an anti-inflammatory macrophage phenotype through EP4","volume":"19","author":"Heffron","year":"2021","journal-title":"J Thromb Haemost."},{"key":"B242","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jbm.a.36792","article-title":"Anti-inflammation effects of injectable platelet-rich fibrin via macrophages and dendritic cells","volume":"108","author":"Zhang","year":"2020","journal-title":"J Biomed Mat Res Part A."},{"key":"B243","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3390\/ijms22052336","article-title":"Effect of platelet-rich plasma on M1\/M2 macrophage polarization","volume":"22","author":"Uchiyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B244","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10238-025-01651-w","article-title":"Platelet-rich plasma-derived exosomes accelerate the healing of diabetic foot ulcers by promoting macrophage polarization toward the M2 phenotype","volume":"25","author":"He","year":"2025","journal-title":"Clin Exp Med."},{"key":"B245","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.19746\/j.cnki.issn.1009-2137.2023.05.037","volume":"31","author":"Shi","year":"2023","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi."},{"key":"B246","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.4049\/jimmunol.172.9.5297","article-title":"Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro","volume":"172","author":"Hagihara","year":"2004","journal-title":"J Immunol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijmm.2016.11.010","article-title":"Influence of platelet-rich plasma on the immune response of human monocyte-derived dendritic cells and macrophages stimulated with Aspergillus fumigatus","volume":"307","author":"Czakai","year":"2017","journal-title":"Int J Med Microbiol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/term.2361","article-title":"Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing","volume":"12","author":"Papait","year":"2018","journal-title":"J Tissue Eng Regen Med."},{"key":"B249","doi-asserted-by":"publisher","first-page":"12805","DOI":"10.1038\/s41598-025-97501-6","article-title":"Platelet-rich plasma relieves inflammation and pain by regulating M1\/M2 macrophage polarization in knee osteoarthritis rats","volume":"15","author":"Xu","year":"2025","journal-title":"Sci Rep."},{"key":"B250","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.reth.2020.03.009","article-title":"Platelet-rich plasma promotes recruitment of macrophages in the process of tendon healing","volume":"14","author":"Nishio","year":"2020","journal-title":"Regen Ther."},{"key":"B251","doi-asserted-by":"publisher","first-page":"1399130","DOI":"10.3389\/fimmu.2024.1399130","article-title":"Immunoregulatory role of platelet derivatives in the macrophage-mediated immune response","volume":"15","author":"Anitua","year":"2024","journal-title":"Front Immunol"},{"key":"B252","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1182\/bloodadvances.2020002867","article-title":"Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-\u03b2 expression by cDCs and monocytes in mice","volume":"4","author":"Tran","year":"2020","journal-title":"Blood Adv."},{"key":"B253","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/jth.12612","article-title":"Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation","volume":"12","author":"Zhu","year":"2014","journal-title":"J Thromb Haemost."},{"key":"B254","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.3390\/ijms262110804","article-title":"Platelet-rich plasma (PRP): molecular mechanisms, actions and clinical applications in human body","volume":"26","author":"Wu","year":"2025","journal-title":"Int J Mol Sci."},{"key":"B255","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.reth.2021.08.010","article-title":"Characterization of autologous platelet rich plasma (PRP) and its biological effects in patients with Beh\u00e7et's Disease","volume":"18","author":"Huber","year":"2021","journal-title":"Regen Ther."},{"key":"B256","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.3390\/cancers12123653","article-title":"Platelet-derived GARP induces peripheral regulatory T cells-potential impact on T cell suppression in patients with melanoma-associated thrombocytosis","volume":"12","author":"Zimmer","year":"2020","journal-title":"Cancers"},{"key":"B257","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","article-title":"Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents","volume":"116","author":"Bao","year":"2010","journal-title":"Blood."},{"key":"B258","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s40364-024-00700-y","article-title":"Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy","volume":"12","author":"Yan","year":"2024","journal-title":"Biomark Res."},{"key":"B259","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2018.00406","article-title":"Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and tregs during tissue inflammation","volume":"9","author":"Ponomarev","year":"2018","journal-title":"Front Immunol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","article-title":"The role of platelets in immune-mediated inflammatory diseases","volume":"23","author":"Scherlinger","year":"2023","journal-title":"Nat Rev Immunol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/medicina59040746","article-title":"Efficacy of platelet-rich plasma therapy in oral lichen planus: a systematic review","volume":"59","author":"Sriram","year":"2023","journal-title":"Medicina."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1692916","DOI":"10.3389\/fimmu.2025.1692916","article-title":"Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence","volume":"16","author":"Tian","year":"2025","journal-title":"Front Immunol"},{"key":"B263","doi-asserted-by":"publisher","first-page":"e50356","DOI":"10.7759\/cureus.50356","article-title":"Platelet-rich plasma for the treatment of plaque psoriasis: a systematic review","volume":"15","author":"Bunjaj","year":"2023","journal-title":"Cureus."},{"key":"B264","doi-asserted-by":"publisher","first-page":"e74252","DOI":"10.7759\/cureus.74252","article-title":"Lagr\u00e1n Z, Alkhraisat MH. Bioactive effect of plasma-rich in growth factors (PRGFs) on cell-based in vitro models of skin inflammation in relation to inflammatory skin disorders","volume":"16","author":"Anitua","year":"2024","journal-title":"Cureus."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1089\/ten.tea.2010.0729","article-title":"Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response","volume":"17","author":"El Backly","year":"2011","journal-title":"Tissue Eng Part A."},{"key":"B266","doi-asserted-by":"publisher","first-page":"101830","DOI":"10.1016\/j.tice.2022.101830","article-title":"Platelet-rich plasma contributes to chondroprotection by repairing mitochondrial function via AMPK\/NF-\u03baB signaling in osteoarthritic chondrocytes","volume":"77","author":"Li","year":"2022","journal-title":"Tissue Cell."},{"key":"B267","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/biom11070954","article-title":"del Olmo-Aguado S, Garc\u00eda-P\u00e9rez E, Fern\u00e1ndez-Vega-Cueto L, Fern\u00e1ndez-Vega Cueto A, Baamonde-Arbaiza B, et al. Plasma rich in growth factors promotes autophagy in ARPE19 cells in response to oxidative stress induced by blue light","volume":"11","author":"Su\u00e1rez-Barrio","year":"2021","journal-title":"Biomolecules"},{"key":"B268","doi-asserted-by":"publisher","first-page":"111106","DOI":"10.1016\/j.cellsig.2024.111106","article-title":"Platelet-rich plasma-derived extracellular vesicles inhibit NF-\u03baB\/NLRP3 pathway-mediated pyroptosis in intervertebral disc degeneration via the MALAT1\/microRNA-217\/SIRT1 axis","volume":"117","author":"Tao","year":"2024","journal-title":"Cell Signal."},{"key":"B269","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.3390\/ijms241713043","article-title":"Advances in platelet rich plasma-derived extracellular vesicles for regenerative medicine: a systematic-narrative review","volume":"24","author":"Anitua","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B270","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1177\/0363546511419278","article-title":"Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes","volume":"39","author":"van Buul","year":"2011","journal-title":"Am J Sports Med."},{"key":"B271","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar4493","article-title":"Biology of platelet-rich plasma and its clinical application in cartilage repair","volume":"16","author":"Xie","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B272","doi-asserted-by":"publisher","first-page":"e28663","DOI":"10.1371\/journal.pone.0028663","article-title":"IGF-1 and PDGF-bb suppress IL-1\u03b2-induced cartilage degradation through down-regulation of NF-\u03baB signaling: involvement of Src\/PI-3K\/AKT pathway","volume":"6","author":"Montaseri","year":"2011","journal-title":"PLoS ONE."},{"key":"B273","doi-asserted-by":"publisher","first-page":"e1254597","DOI":"10.1155\/jdr\/1254597","article-title":"Mechanism of platelet-rich plasma in promoting diabetic wound healing via the PI3K\/AKT signaling pathway to regulate collagen synthesis and angiogenesis","volume":"2026","author":"Liu","year":"2026","journal-title":"J Diabetes Res."},{"key":"B274","doi-asserted-by":"publisher","first-page":"11493","DOI":"10.1038\/s41598-021-90174-x","article-title":"In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis","volume":"11","author":"Zahir","year":"2021","journal-title":"Sci Rep."},{"key":"B275","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/onc.2012.171","article-title":"TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers","volume":"32","author":"Freudlsperger","year":"2013","journal-title":"Oncogene."},{"key":"B276","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/ijms24010770","article-title":"microRNAs are abundant and stable in platelet-rich fibrin and other autologous blood products of canines","volume":"24","author":"Jasineviciute","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B277","doi-asserted-by":"publisher","first-page":"13299","DOI":"10.3390\/ijms241713299","article-title":"Platelets rich plasma increases antioxidant defenses of tenocytes via Nrf2 signal pathway","volume":"24","author":"Tognoloni","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B278","doi-asserted-by":"publisher","first-page":"e70228","DOI":"10.1111\/jocd.70228","article-title":"Platelet-released growth factors (PRGFs) activate NRF2-ARE and modulate inflammatory response in an nrf2-dependent manner in primary human keratinocytes","volume":"24","author":"Stein","year":"2025","journal-title":"J Cosmet Dermatol."},{"key":"B279","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/toxics11050398","article-title":"Platelet rich plasma and adipose-derived mesenchymal stem cells mitigate methotrexate-induced nephrotoxicity in rat via Nrf2\/Ppar\u03b3\/HO-1 and NF-?","volume":"11","author":"Wani","year":"2023","journal-title":"Toxics"},{"key":"B280","doi-asserted-by":"publisher","first-page":"14219","DOI":"10.1038\/s41598-025-98998-7","article-title":"Platelet-rich plasma and IL-1\u03b2 antagonist receptor peptide attenuate the inflammatory process of muscle injury in wistar rats","volume":"15","author":"Colares","year":"2025","journal-title":"Sci Rep."},{"key":"B281","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/term.3198","article-title":"Wnt5a\/Platelet-rich plasma synergistically inhibits IL-1\u03b2-induced inflammatory activity through NF-\u03baB signaling pathway and prevents cartilage damage and promotes meniscus regeneration","volume":"15","author":"Qi","year":"2021","journal-title":"J Tissue Eng Regen Med."},{"key":"B282","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s11999-015-4179-z","article-title":"Platelet-rich plasma modulates the secretion of inflammatory\/angiogenic proteins by inflamed tenocytes","volume":"473","author":"Andia","year":"2015","journal-title":"Clin Orthop Relat Res."},{"key":"B283","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s00167-014-3113-3","article-title":"Effect of two different preparations of platelet-rich plasma on synoviocytes","volume":"23","author":"Assirelli","year":"2015","journal-title":"Knee Surg Sports Traumatol Arthroscopy."},{"key":"B284","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0363546513507766","article-title":"The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis","volume":"42","author":"Sundman","year":"2014","journal-title":"Am J Sports Med."},{"key":"B285","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/jor.22532","article-title":"Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-\u03b1 and IL-1","volume":"32","author":"Kim","year":"2014","journal-title":"J Orthopaed Res."},{"key":"B286","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2217\/rme-2017-0122","article-title":"Pure platelet-rich plasma and supernatant of calcium-activated P-PRP induce different phenotypes of human macrophages","volume":"13","author":"Escobar","year":"2018","journal-title":"Regen Med."},{"key":"B287","doi-asserted-by":"publisher","first-page":"1463216","DOI":"10.1155\/2017\/1463216","article-title":"Activated platelets induce an anti-inflammatory response of monocytes\/macrophages through cross-regulation of PGE and cytokines","volume":"2017","author":"Linke","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B288","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.4049\/jimmunol.1201103","article-title":"Activated platelets enhance IL-10 secretion and reduce TNF-\u03b1 secretion by monocytes","volume":"191","author":"Gudbrandsdottir","year":"2013","journal-title":"J Immunol"},{"key":"B289","doi-asserted-by":"publisher","first-page":"1721727X221112271","DOI":"10.1177\/1721727X221112271","article-title":"Platelet-rich plasma improves lipopolysaccharide-induced inflammatory response by upgrading autophagy","volume":"20","author":"Li","year":"2022","journal-title":"Euro J Inflamm"},{"key":"B290","doi-asserted-by":"publisher","first-page":"10746","DOI":"10.3389\/ebm.2025.10746","article-title":"Platelet-rich plasma in peripheral nerve injury repair: a comprehensive review of mechanisms, clinical applications, and therapeutic potential","volume":"250","author":"Shang","year":"2025","journal-title":"Exp Biol Med."},{"key":"B291","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1089\/ten.tea.2012.0225","article-title":"Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution","volume":"19","author":"Pereira","year":"2013","journal-title":"Tissue Eng Part A."},{"key":"B292","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3892\/mmr.2017.6365","article-title":"Comparative evaluation of the effects of platelet-rich plasma formulations on extracellular matrix formation and the NF-\u03baB signaling pathway in human articular chondrocytes","volume":"15","author":"Yin","year":"2017","journal-title":"Mol Med Rep."},{"key":"B293","doi-asserted-by":"publisher","first-page":"17487","DOI":"10.3390\/ijms242417487","article-title":"Elevated IL-1\u03b2 and comparable IL-1 receptor antagonist levels are characteristic features of L-PRP in female college athletes compared to male professional soccer players","volume":"24","author":"Mochizuki","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B294","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/09537104.2012.684730","article-title":"The role of platelet-rich plasma in tissue regeneration","volume":"24","author":"Alsousou","year":"2013","journal-title":"Platelets."},{"key":"B295","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.3390\/ijms24065367","article-title":"Action of platelet-rich plasma on in vitro cellular bioactivity: more than platelets","volume":"24","author":"Beitia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B296","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb Haemost."},{"key":"B297","doi-asserted-by":"publisher","first-page":"8583","DOI":"10.3390\/jcm14238583","article-title":"Platelet-rich plasma (PRP) and recombinant growth factor therapies in cutaneous wound healing: mechanisms, clinical applications, and future directions","volume":"14","author":"Ahmed","year":"2025","journal-title":"J Clin Med"},{"key":"B298","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.retram.2016.06.003","article-title":"Skin fibrosis: models and mechanisms","volume":"64","author":"Do","year":"2016","journal-title":"Curr Res Transl Med."},{"key":"B299","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature."},{"key":"B300","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/jcmm.12847","article-title":"The role of TGF-\u03b21\/Smad2\/3 pathway in platelet-rich plasma in retarding intervertebral disc degeneration","volume":"20","author":"Yang","year":"2016","journal-title":"J Cell Mol Med."},{"key":"B301","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1038\/s41598-017-03113-0","article-title":"Platelet-rich plasma respectively reduces and promotes adipogenic and myofibroblastic differentiation of human adipose-derived stromal cells via the TGF\u03b2 signalling pathway","volume":"7","author":"Chignon-Sicard","year":"2017","journal-title":"Sci Rep."},{"key":"B302","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3109\/02713683.2014.978478","article-title":"Platelet-rich plasma prolongs myofibroblast accumulation in corneal stroma with incisional wound","volume":"40","author":"Koulikovska","year":"2015","journal-title":"Curr Eye Res."},{"key":"B303","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaut.2017.07.002","article-title":"Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications","volume":"83","author":"Iizuka-Koga","year":"2017","journal-title":"J Autoimmun."},{"key":"B304","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/mi.2010.7","article-title":"Molecular mechanisms regulating TGF-\u03b2-induced Foxp3 expression","volume":"3","author":"Xu","year":"2010","journal-title":"Mucosal Immunol."},{"key":"B305","doi-asserted-by":"publisher","first-page":"1078527","DOI":"10.3389\/fbioe.2022.1078527","article-title":"Platelet-rich plasma attenuates the severity of joint capsule fibrosis following post-traumatic joint contracture in rats","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Bioeng Biotechnol."},{"key":"B306","doi-asserted-by":"publisher","first-page":"15627","DOI":"10.1002\/jcp.28211","article-title":"Platelet-rich plasma promotes the regeneration of cartilage engineered by mesenchymal stem cells and collagen hydrogel via the TGF-\u03b2\/SMAD signaling pathway","volume":"234","author":"Fang","year":"2019","journal-title":"J Cell Physiol."},{"key":"B307","doi-asserted-by":"publisher","first-page":"158","DOI":"10.14715\/cmb\/2024.70.4.25","article-title":"Injectable platelet-rich fibrin promotes proliferation and trichogenic inductivity of dermal papilla cells through activating TGF-\u03b2\/Smad signaling pathway","volume":"70","author":"Xu","year":"2024","journal-title":"Cell Mol Biol."},{"key":"B308","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1007\/s00266-025-05136-9","article-title":"Autologous fat granules combined with PRP treat hypertrophic scars through TGF-\u03b2\/Smad signaling pathway","volume":"49","author":"Yang","year":"2025","journal-title":"Aesthetic Plast Surg."},{"key":"B309","doi-asserted-by":"publisher","first-page":"1734266","DOI":"10.3389\/fcell.2026.1734266","article-title":"Platelet-rich plasma (PRP) bidirectionally modulates scar formation via the Piezo1-YAP\/TAZ axis: a novel mechanotransduction hypothesis","volume":"14","author":"Tian","year":"2026","journal-title":"Front Cell Dev Biol."},{"key":"B310","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.0306068101","article-title":"Hepatocyte growth factor\/c-met signaling pathway is required for efficient liver regeneration and repair","volume":"101","author":"Huh","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B311","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/wound.2011.0326","article-title":"Epidermal growth factor and epidermal growth factor receptor: the yin and yang in the treatment of cutaneous wounds and cancer","volume":"2","author":"Bodnar","year":"2013","journal-title":"Adv Wound Care."},{"key":"B312","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","article-title":"Regulation of wound healing by growth factors and cytokines","volume":"83","author":"Werner","year":"2003","journal-title":"Physiol Rev."},{"key":"B313","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2013-03-492801","article-title":"Activated platelets can deliver mRNA regulatory Ago2\u2022microRNA complexes to endothelial cells via microparticles","volume":"122","author":"Laffont","year":"2013","journal-title":"Blood."},{"key":"B314","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B315","doi-asserted-by":"publisher","first-page":"1623780","DOI":"10.3389\/fbioe.2025.1623780","article-title":"Platelet-rich plasma may accelerate diabetic wound healing by modulating epithelial\/endothelial-mesenchymal transition through inhibiting reactive oxygen species-mediated oxidative stress","volume":"13","author":"Li","year":"2025","journal-title":"Front Bioeng Biotechnol."},{"key":"B316","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.3390\/ijms21186519","article-title":"Leucocyte-rich platelet-rich plasma enhances fibroblast and extracellular matrix activity: implications in wound healing","volume":"21","author":"Devereaux","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B317","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.20944\/preprints202306.0745.v1","article-title":"Angiogenesis and tissue repair depend on platelet dosing and bioformulation strategies following orthobiological platelet-rich plasma procedures: a narrative review","volume":"11","author":"Everts","year":"2023","journal-title":"Biomedicines"},{"key":"B318","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mvr.2013.04.008","article-title":"Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway","volume":"89","author":"Mammoto","year":"2013","journal-title":"Microvasc Res."},{"key":"B319","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/dermatopathology13010002","article-title":"Increased expression of angiopoietin 2 and Tie2 in Rosacea","volume":"13","author":"Kaya","year":"2025","journal-title":"Dermatopathology"},{"key":"B320","doi-asserted-by":"publisher","first-page":"ozag017","DOI":"10.1093\/mam\/ozag017","article-title":"Effect of platelet-rich plasma versus platelet lysate on imiquimod-induced psoriasis-like skin inflammation in adult male albino rat model: a histological, immunohistochemical, and ultrastructural study","volume":"32","author":"El-Beltagi","year":"2026","journal-title":"Microscopy Microanal"},{"key":"B321","doi-asserted-by":"publisher","first-page":"e70152","DOI":"10.1111\/exd.70152","article-title":"Platelet-derived extracellular vesicles alleviate psoriatic inflammation via mitochondrial transfer to macrophages","volume":"34","author":"Wang","year":"2025","journal-title":"Exp Dermatol."},{"key":"B322","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12967-019-2044-7","article-title":"Platelet-rich plasma activates AKT signaling to promote wound healing in a mouse model of radiation-induced skin injury","volume":"17","author":"Lee","year":"2019","journal-title":"J Transl Med."},{"key":"B323","doi-asserted-by":"publisher","first-page":"tkaa028","DOI":"10.1093\/burnst\/tkaa028","article-title":"Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization","volume":"8","author":"Xu","year":"2020","journal-title":"Burns Trauma"},{"key":"B324","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/prd.12565","article-title":"How to explain the beneficial effects of platelet-rich plasma","volume":"97","author":"Gruber","year":"2000","journal-title":"Periodontology."},{"key":"B325","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":"Growth factors and cytokines in wound healing","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen."},{"key":"B326","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jobcr.2024.02.007","article-title":"Regenerative potential of platelet concentrates in chronic oral mucosal lesions","volume":"14","author":"Hijazi","year":"2024","journal-title":"J Oral Biol Craniofac Res"},{"key":"B327","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/exd.13731","article-title":"The skin barrier: epidermis vs. environment","volume":"27","author":"Eckhart","year":"2018","journal-title":"Exp Dermatol."},{"key":"B328","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/life14010040","article-title":"Platelet-rich plasma in dermatology: new insights on the cellular mechanism of skin repair and regeneration","volume":"14","author":"Manole","year":"2023","journal-title":"Life."},{"key":"B329","doi-asserted-by":"publisher","first-page":"5671615","DOI":"10.1155\/2017\/5671615","article-title":"Platelet-released growth factors induce differentiation of primary keratinocytes","volume":"2017","author":"Bayer","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B330","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.3390\/ijms23158370","article-title":"Platelet derivatives and the immunomodulation of wound healing","volume":"23","author":"Scopelliti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B331","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B332","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jid.2021.12.005","article-title":"Skin deep: the role of the microbiota in cutaneous autoimmunity","volume":"142","author":"Pereira","year":"2022","journal-title":"J Invest Dermatol."},{"key":"B333","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/microorganisms7090279","article-title":"Microbiota and immune-mediated skin diseases-an overview","volume":"7","author":"Catinean","year":"2019","journal-title":"Microorganisms."},{"key":"B334","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41579-020-0367-2","article-title":"Host-microbiota interactions in immune-mediated diseases","volume":"18","author":"Ruff","year":"2020","journal-title":"Nat Rev Microbiol."},{"key":"B335","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Exp Dermatol."},{"key":"B336","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ame2.12414","article-title":"Characterization of distinct microbiota associated with androgenetic alopecia patients treated and untreated with platelet-rich plasma (PRP)","volume":"7","author":"Zhang","year":"2024","journal-title":"Anim Models Exp Med."},{"key":"B337","doi-asserted-by":"publisher","first-page":"e51360","DOI":"10.7759\/cureus.51360","article-title":"Antimicrobial effects of platelet-rich plasma and platelet-rich fibrin: a scoping review","volume":"15","author":"Cl","year":"2023","journal-title":"Cureus."},{"key":"B338","doi-asserted-by":"publisher","first-page":"1757780","DOI":"10.3389\/fcimb.2026.1757780","article-title":"In vitro antibacterial activity of platelet-rich plasma against gram-positive and gram-negative pathogens","volume":"16","author":"Liu","year":"2026","journal-title":"Front Cell Infect Microbiol."},{"key":"B339","doi-asserted-by":"publisher","first-page":"50351","DOI":"10.3791\/50351","article-title":"PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP","volume":"9","author":"Li","year":"2013","journal-title":"J Visual Exp."},{"key":"B340","doi-asserted-by":"publisher","first-page":"15145","DOI":"10.1038\/s41598-025-97418-0","article-title":"Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections","volume":"15","author":"Aboelsaad","year":"2025","journal-title":"Sci Rep."},{"key":"B341","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/ten.teb.2018.0309","article-title":"Platelet-rich plasma for the treatment of tissue infection: preparation and clinical evaluation","volume":"25","author":"Zhang","year":"2019","journal-title":"Tissue Eng Part B Rev."},{"key":"B342","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13019-021-01652-2","article-title":"Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent","volume":"16","author":"Sethi","year":"2021","journal-title":"J Cardiothorac Surg."},{"key":"B343","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12896-025-01078-x","article-title":"Antibacterial and antibiofilm activity of platelet-rich plasma under different activation conditions against multidrug-resistant MRSA isolated from human skin abscesses","volume":"25","author":"Abdelgeliel","year":"2025","journal-title":"BMC Biotechnol."},{"key":"B344","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/adhm.201200465","article-title":"Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection","volume":"2","author":"Li","year":"2013","journal-title":"Adv Healthc Mater."},{"key":"B345","first-page":"864","article-title":"An experimental study on antimicrobial efficacy of platelet-rich plasma for bone infection prophylaxis","volume":"24","author":"Jia","year":"2010","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi."},{"key":"B346","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.3390\/jcm12124129","article-title":"Effectiveness of platelet-rich plasma injections as prophylaxis for recurrent urinary tract infection in women","volume":"12","author":"Lee","year":"2023","journal-title":"J Clin Med"},{"key":"B347","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2180-13-47","article-title":"Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity","volume":"13","author":"Drago","year":"2013","journal-title":"BMC Microbiol."},{"key":"B348","doi-asserted-by":"publisher","first-page":"79","DOI":"10.11138\/mltj\/2014.4.1.079","article-title":"In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood","volume":"4","author":"Intravia","year":"2014","journal-title":"Muscles Ligaments Tendons J."},{"key":"B349","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00068-018-0957-0","article-title":"Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study","volume":"45","author":"\u00c7etinkaya","year":"2019","journal-title":"Euro J Trauma Emerg Surg."},{"key":"B350","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/iwj.13545","article-title":"An evaluation of the bacteriostatic effect of platelet-rich plasma","volume":"18","author":"Smith","year":"2021","journal-title":"Int Wound J."},{"key":"B351","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/IDR.S186651","article-title":"Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds","volume":"12","author":"Li","year":"2019","journal-title":"Infect Drug Resist."},{"key":"B352","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1302\/0301-620X.89B3.18491","article-title":"Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study","volume":"89","author":"Bielecki","year":"2007","journal-title":"J Bone Joint Surg."},{"key":"B353","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12866-015-0482-9","article-title":"Leukocyte presence does not increase microbicidal activity of platelet-rich plasma in vitro","volume":"15","author":"Mariani","year":"2015","journal-title":"BMC Microbiol."},{"key":"B354","doi-asserted-by":"publisher","first-page":"9471723","DOI":"10.1155\/2018\/9471723","article-title":"Antibacterial activity of leukocyte- and platelet-rich plasma: an in vitro study","volume":"2018","author":"Cie\u015blik-Bielecka","year":"2018","journal-title":"Biomed Res Int."},{"key":"B355","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.burns.2020.05.019","article-title":"Efficacy of topical platelet-rich plasma and chitosan co-administration on Candida albicans-infected partial thickness burn wound healing","volume":"46","author":"Farjah","year":"2020","journal-title":"Burns."},{"key":"B356","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bjps.2022.11.059","article-title":"Effectiveness of topical administration of platelet-rich plasma on the healing of methicillin-resistant Staphylococcus aureus-infected full-thickness wound model","volume":"77","author":"Leisi","year":"2023","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"B357","doi-asserted-by":"publisher","first-page":"87","DOI":"10.18773\/austprescr.2025.026","article-title":"Psoriasis: an update on topical and systemic therapies","volume":"48","author":"Chan","year":"2025","journal-title":"Austral Prescrib."},{"key":"B358","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B359","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jaad.2025.05.1386","article-title":"Focused update: guidelines of care for the management of atopic dermatitis in adults","volume":"93","author":"Davis","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B360","doi-asserted-by":"publisher","first-page":"587","DOI":"10.5694\/mja2.51560","article-title":"Management of atopic dermatitis: a narrative review","volume":"216","author":"Goh","year":"2022","journal-title":"Med J Aust."},{"key":"B361","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11882-022-01047-w","article-title":"Biologics and small molecule inhibitors: an update in therapies for allergic and immunologic skin diseases","volume":"22","author":"Dodson","year":"2022","journal-title":"Curr Allergy Asthma Rep."},{"key":"B362","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00403-018-1808-x","article-title":"Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review","volume":"310","author":"Florek","year":"2018","journal-title":"Arch Dermatol Res."},{"key":"B363","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/jamadermatol.2024.2517","article-title":"Long-term effectiveness and reasons for discontinuation of dupilumab in patients with atopic dermatitis","volume":"160","author":"Boesjes","year":"2024","journal-title":"JAMA Dermatol."},{"key":"B364","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/all.70061","article-title":"Biologics to treat atopic dermatitis: effectiveness, safety, and future directions","volume":"81","author":"de Bruin-Weller","year":"2026","journal-title":"Allergy."},{"key":"B365","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.jaip.2025.04.042","article-title":"Deciding which patients with atopic dermatitis to prioritize for biologics and janus kinase inhibitors","volume":"13","author":"Kamata","year":"2025","journal-title":"J Allergy Clin Immunol."},{"key":"B366","doi-asserted-by":"publisher","first-page":"14961","DOI":"10.2147\/JIR.S554375","article-title":"Mechanisms underlying lichen planus in association with biologic therapy","volume":"18","author":"Podolsky","year":"2025","journal-title":"J Inflamm Res."},{"key":"B367","volume-title":"Cellular and Molecular Immunology E-Book","author":"Abbas","year":"2021"},{"key":"B368","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1741-7015-11-88","article-title":"Biologic therapy for autoimmune diseases: an update","volume":"11","author":"Rosman","year":"2013","journal-title":"BMC Med."},{"key":"B369","doi-asserted-by":"publisher","first-page":"414","DOI":"10.37765\/ajmc.2025.89774","article-title":"US health care disparities in immunology biologics access: a systematic review","volume":"31","author":"Wright","year":"2025","journal-title":"Am J Manag Care."},{"key":"B370","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.21608\/mjcu.2018.56346","article-title":"Interleukin 17 expression in psoriatic skin lesions before and after treatment with platelet rich plasma (PrP)","volume":"86","author":"Mona","year":"2018","journal-title":"Med J Cairo Univ"},{"key":"B371","doi-asserted-by":"publisher","first-page":"e18472","DOI":"10.7759\/cureus.18472","article-title":"Can platelet-rich plasma reduce the burden of inflammatory skin diseases such as psoriasis and atopic dermatitis?","volume":"13","author":"Kauhl","year":"2021","journal-title":"Cureus"},{"key":"B372","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/dth.12388","article-title":"Clinical efficacy of platelet rich plasma in combination with methotrexate in chronic plaque psoriatic patients","volume":"29","author":"Chakravdhanula","year":"2016","journal-title":"Dermatol Ther."},{"key":"B373","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21608\/bjas.2018.179330","article-title":"Evaluation of platelet rich plasma in the management of psoriasis","volume":"3","author":"Rahman","year":"2018","journal-title":"Benha J Appl Sci."},{"key":"B374","doi-asserted-by":"publisher","first-page":"233","DOI":"10.66344\/jpad.v32i2.1854","article-title":"Efficacy of intralesional injection of platlet rich plasma in combination with methoterexate in chronic plaque psoriasis","volume":"32","author":"Anwar","year":"2022","journal-title":"J Pak Assoc Dermatol."},{"key":"B375","first-page":"22","article-title":"Platelet-rich plasma use in the treatment of eczema (Atopic dermatitis): case report","volume":"6","author":"Ghani","year":"2018","journal-title":"Glob Sci J"},{"key":"B376","doi-asserted-by":"publisher","first-page":"129","DOI":"10.17532\/jhsci.2023.2178","article-title":"The efficacy and safety of autologous activated platelet-rich plasma therapy as adjuvant treatment of atopic dermatitis in pregnant woman","volume":"13","author":"Karina","year":"2023","journal-title":"J Health Sci."},{"key":"B377","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jdcr.2020.10.036","article-title":"Long-term control of atopic dermatitis with platelet-rich plasma","volume":"7","author":"Vafaei-Nodeh","year":"2021","journal-title":"JAAD Case Rep."},{"key":"B378","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.2147\/CCID.S379323","article-title":"An autologous topical serum derived from platelet-rich plasma therapy for the management of sensitive skin alterations: a case series report","volume":"15","author":"Garc\u00eda-Millan","year":"2022","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"B379","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1111\/jocd.14170","article-title":"Possible clinical efficacy and tolerability of platelet-rich plasma with atopic dermatitis","volume":"20","author":"Yosef","year":"2021","journal-title":"J Cosmet Dermatol."},{"key":"B380","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1111\/jocd.14469","article-title":"Excellent response with platelet-rich plasma treatment in a case of steroid-induced rosacea-like dermatitis","volume":"21","author":"Konu\u015f","year":"2022","journal-title":"J Cosmet Dermatol."},{"key":"B381","first-page":"22","article-title":"Resultados del plasma rico en plaquetas como tratamiento coadyuvante en la dermatitis seborreica en una cl\u00ednica privada. Asunci\u00f3n, 2024","volume":"1","author":"Alvarez","year":"2025","journal-title":"Ciencia y Est\u00e9tica"},{"key":"B382","doi-asserted-by":"publisher","first-page":"1576458","DOI":"10.3389\/fonc.2025.1576458","article-title":"Autologous platelet-rich gel versus vitamin B12 for the treatment of grade III-IV acute radiation dermatitis in malignant tumor patients undergoing radiotherapy: an open-label randomized controlled clinical trial","volume":"15","author":"Tao","year":"2025","journal-title":"Front Oncol."},{"key":"B383","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jpra.2024.11.017","article-title":"Xenogeneic platelet-rich plasma lotion for preventing acute radiation dermatitis in patients with breast cancer undergoing radiotherapy: An open-label, randomized controlled trial","volume":"43","author":"Chen","year":"2025","journal-title":"JPRAS open."},{"key":"B384","first-page":"552","article-title":"Severe skin radiodermatitis fully healed with the use of platelet gel and a hyperbaric chamber","volume":"14","author":"Piccin","year":"2016","journal-title":"Blood Transfus."},{"key":"B385","doi-asserted-by":"publisher","first-page":"e34779","DOI":"10.1097\/MD.0000000000034779","article-title":"Homologous platelet gel on radiation-induced dermatitis in a patient receiving head and neck radiotherapy plus cetuximab: a case report","volume":"102","author":"Guberti","year":"2023","journal-title":"Medicine."},{"key":"B386","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00520-012-1635-0","article-title":"Platelet gel in cutaneous radiation dermatitis","volume":"21","author":"Iervolino","year":"2013","journal-title":"Support Care Cancer."},{"key":"B387","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.3390\/jcm14155368","article-title":"Platelet-rich concentrates in the management of lichen planus\u2014a comprehensive review","volume":"14","author":"Slebioda","year":"2025","journal-title":"J Clin Med."},{"key":"B388","doi-asserted-by":"publisher","first-page":"439","DOI":"10.18203\/2319-2003.ijbcp20231125","article-title":"kamarthi N, Sumit G, Sangeeta M, Swati G, Abhinav S. Comparative evaluation of autologous platelet rich plasma and triamcinolone acetonide injection in the management of erosive lichen planus and oral submucous fibrosis: a clinical study","volume":"12","author":"Sharma","year":"2023","journal-title":"Int J Basic Clin Pharmacol."},{"key":"B389","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jobcr.2020.09.008","article-title":"Comparative evaluation of effectiveness of autologous platelet rich plasma and intralesional corticosteroids in the management of erosive oral Lichen planus- a clinical study","volume":"10","author":"Sethi Ahuja","year":"2020","journal-title":"J Oral Biol Craniofac Res."},{"key":"B390","doi-asserted-by":"publisher","first-page":"e20210180","DOI":"10.1590\/1678-7757-2021-0180","article-title":"Efficacy of injectable platelet-rich fibrin in the erosive oral lichen planus: a split-mouth, randomized, controlled clinical trial","volume":"29","author":"Saglam","year":"2021","journal-title":"J Appl Oral Sci."},{"key":"B391","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1111\/odi.14261","article-title":"Efficacy of injectable platelet-rich fibrin in the treatment of symptomatic oral lichen planus","volume":"29","author":"Al-Hallak","year":"2023","journal-title":"Oral Dis."},{"key":"B392","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/cre2.550","article-title":"Efficacy of intralesional injections of platelet-rich plasma in patients with oral lichen planus: a pilot randomized clinical trial","volume":"8","author":"Hijazi","year":"2022","journal-title":"Clin Exp Dent Res."},{"key":"B393","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1007\/s00784-020-03702-w","article-title":"Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study","volume":"25","author":"Bennardo","year":"2021","journal-title":"Clin Oral Investig."},{"key":"B394","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37506\/ijocd.v11i2.20053","article-title":"Comparative evaluation of intralesional injection of autologous platelet rich plasma versus intralesional injection of corticosteroids in the management of resistant oral lichen planus","volume":"11","author":"Choudhary","year":"2023","journal-title":"Indian J Contemp Dent."},{"key":"B395","doi-asserted-by":"publisher","first-page":"514","DOI":"10.4103\/tdj.tdj_34_24","article-title":"Mucoadhesive mycophenolate mofetil and injectable platelet rich fibrin in the treatment of oral lichen planus","volume":"21","author":"El Araby","year":"2024","journal-title":"Tanta Dent J."},{"key":"B396","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.21608\/edj.2022.146525.2166","article-title":"Efficacy and safety of platelet lysate mucoadhesive gel in the treatment of patients suffering from an erosive form of oral lichen planus: a randomized placebo-controlled clinical trial","volume":"68","author":"Shalby","year":"2022","journal-title":"Egypt Dent J."},{"key":"B397","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/jocd.15622","article-title":"Intralesional injection of platelet-rich plasma versus steroid in the treatment of oral lichen planus","volume":"22","author":"ElGhareeb","year":"2023","journal-title":"J Cosmet Dermatol."},{"key":"B398","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biomedicines6010015","article-title":"Platelet-rich plasma (PRP) rinses for the treatment of non-responding oral lichen planus: a case report","volume":"6","author":"Merigo","year":"2018","journal-title":"Biomedicines"},{"key":"B399","first-page":"1","article-title":"Platelet rich plasma a new prospective in treatment of recalcitrant erosive lichen planus\u2013a case report","volume":"3","author":"Shaik","year":"2020","journal-title":"Int J Res Rep Dent."},{"key":"B400","doi-asserted-by":"publisher","first-page":"457","DOI":"10.21608\/edj.2021.51346.1366","article-title":"Clinical evaluation of the efficiency of intralesional injection of autologous platelet rich plasma in treatment of erosive oral lichen planus","volume":"67","author":"EL-Shinnawi","year":"2021","journal-title":"Egypt Dent J"},{"key":"B401","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4103\/MJBL.MJBL_359_22","article-title":"Effects of intralesional platelets-rich plasma injections on oral lichen planus lesions and salivary interleukin-8","volume":"20","author":"Asal","year":"2023","journal-title":"Med J Babylon."},{"key":"B402","doi-asserted-by":"publisher","first-page":"459","DOI":"10.23736\/S0392-0488.16.05399-2","article-title":"Oral lichen planus: therapy and phenotype","volume":"153","author":"Lor\u00e9","year":"2016","journal-title":"Giornale Italiano Dermatol Venereol."},{"key":"B403","first-page":"330","article-title":"The role of platelet rich plasma injection in the treatment of oral lichen planus patients","volume":"29","author":"Sobhy","year":"2023","journal-title":"Zagazig Univ Med J"},{"key":"B404","doi-asserted-by":"publisher","first-page":"163","DOI":"10.12788\/cutis.0468","article-title":"Oral lichen planus treated with plasma rich in growth factors","volume":"109","author":"Anitua","year":"2022","journal-title":"Cutis."},{"key":"B405","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.aanat.2017.12.006","article-title":"Biomolecules in the treatment of lichen planus refractory to corticosteroid therapy: clinical and histopathological assessment","volume":"216","author":"Pi\u00f1as","year":"2018","journal-title":"Ann Anat."},{"key":"B406","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40257-017-0277-x","article-title":"Biological therapy of refractory ulcerative oral lichen planus with plasma rich in growth factors","volume":"18","author":"Pi\u00f1as","year":"2017","journal-title":"Am J Clin Dermatol."},{"key":"B407","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.36721\/pjps.2024.37.6.reg.1625-1633.1","article-title":"Effectiveness of platelet-rich plasma gel alongside tacrolimus ointment in managing erosive oral lichen planus and its effect on oral immune microenvironment","volume":"37","author":"Huang","year":"2024","journal-title":"Pak J Pharmaceut Sci"},{"key":"B408","doi-asserted-by":"publisher","first-page":"e70455","DOI":"10.1002\/hsr2.70455","article-title":"The efficacy of platelet-rich plasma in facial lichen planus pigmentosus: a prospective pilot study","volume":"8","author":"Kiatsurayanon","year":"2025","journal-title":"Health Sci Rep."},{"key":"B409","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/dth.12343","article-title":"Platelet-rich plasma as a novel treatment for lichen planopillaris","volume":"29","author":"Bolan\u010da","year":"2016","journal-title":"Dermatol Ther."},{"key":"B410","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jaad.2020.06.026","article-title":"Use of platelet-rich plasma in lichen planopilaris and its variants: a retrospective case series demonstrating treatment tolerability without koebnerization","volume":"83","author":"Svigos","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B411","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.jaad.2018.09.013","article-title":"Platelet-rich plasma as an adjunctive treatment in lichen planopilaris","volume":"80","author":"Jha","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B412","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.3390\/jcm14176199","article-title":"Hair transplantation for lichen planopilaris: a case series of five patients","volume":"14","author":"Osipowicz","year":"2025","journal-title":"J Clin Med"},{"key":"B413","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0974-2077.178562","article-title":"Successful hair transplant outcome in cicatricial lichen planus of the scalp by combining scalp and beard hair along with platelet rich plasma","volume":"9","author":"Saxena","year":"2016","journal-title":"J Cutan Aesthet Surg."},{"key":"B414","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1111\/jocd.16302","article-title":"Platelet-rich plasma as a new and successful treatment for lichen planopilaris: a controlled blinded randomized clinical trial","volume":"23","author":"Behrangi","year":"2024","journal-title":"J Cosmet Dermatol."},{"key":"B415","doi-asserted-by":"publisher","first-page":"e13072","DOI":"10.1111\/dth.13072","article-title":"Platelet-rich plasma for treatment resistant frontal fibrosing alopecia: a case report","volume":"32","author":"\u00d6zcan","year":"2019","journal-title":"Dermatol Ther."},{"key":"B416","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/12034754231177599","article-title":"Plasma rich in growth factors as an adjuvant treatment for the management of frontal fibrosing alopecia: a retrospective observational clinical study","volume":"27","author":"Garc\u00eda","year":"2023","journal-title":"J Cutan Med Surg."},{"key":"B417","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jaad.2018.12.060","article-title":"A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus","volume":"80","author":"Goldstein","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B418","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00266-021-02718-1","article-title":"The effect of lipofilling and platelet-rich plasma on patients with moderate-severe vulvar lichen sclerosus who were non-responders to topical clobetasol propionate: a randomized pilot study","volume":"46","author":"Gutierrez-Ontalvilla","year":"2022","journal-title":"Aesthetic Plast Surg."},{"key":"B419","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11255-017-1523-0","article-title":"Autologous platelet-rich plasma (PRP) in chronic penile lichen sclerosus: the impact on tissue repair and patient quality of life","volume":"49","author":"Casabona","year":"2017","journal-title":"Int Urol Nephrol."},{"key":"B420","doi-asserted-by":"publisher","first-page":"e1124","DOI":"10.1097\/GOX.0000000000001124","article-title":"Use of platelet-rich plasma for vulvovaginal autoimmune conditions like lichen sclerosus","volume":"4","author":"Behnia-Willison","year":"2016","journal-title":"Plast Reconstr Surg Glob Open."},{"key":"B421","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaad.2016.07.037","article-title":"Intradermal injection of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus","volume":"76","author":"Goldstein","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B422","doi-asserted-by":"publisher","first-page":"e14032","DOI":"10.1111\/dth.14032","article-title":"Platelet-rich plasma for male genital lichen sclerosus resistant to conventional therapy: first prospective study","volume":"33","author":"Navarrete","year":"2020","journal-title":"Dermatol Ther."},{"key":"B423","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2450\/BloodTransfus.875","article-title":"First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial","volume":"23","author":"Boero","year":"2025","journal-title":"Blood Transfus."},{"key":"B424","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s00404-024-07424-2","article-title":"Is there a role for platelet rich plasma injection in vulvar lichen sclerosus? A self-controlled pilot study","volume":"309","author":"Boero","year":"2024","journal-title":"Arch Gynecol Obstet."},{"key":"B425","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1080\/09546634.2020.1854650","article-title":"Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?","volume":"33","author":"Tedesco","year":"2022","journal-title":"J Dermatol Treat."},{"key":"B426","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1111\/jdv.15190","article-title":"The use of PRP (platelet-rich plasma) in patients affected by genital lichen sclerosus: clinical analysis and results","volume":"33","author":"Tedesco","year":"2019","journal-title":"J Euro Acad Dermatol Venereol."},{"key":"B427","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/09546634.2019.1685644","article-title":"Usefulness of video thermography in the evaluation of platelet-rich plasma effectiveness in vulvar lichen sclerosus: preliminary study","volume":"32","author":"Tedesco","year":"2021","journal-title":"J Dermatolog Treat."},{"key":"B428","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00403-023-02529-1","article-title":"de la Cruz Cea L, Oreja Cuesta AB. Mid-term symptomatic relief after platelet-rich plasma infiltration in vulvar lichen sclerosus","volume":"315","author":"Medina Garrido","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"B429","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/LGT.0000000000000491","article-title":"Evaluating in office surgery followed by platelet rich plasma to treat lichen sclerosus","volume":"23","author":"Posey","year":"2019","journal-title":"J Lower Genit Tract Dis"},{"key":"B430","doi-asserted-by":"publisher","first-page":"a262","DOI":"10.5826\/dpc.1404a262","article-title":"Management of lichen sclerosus and related comorbidities at a tertiary referral center: beyond topical steroids","volume":"14","author":"Paganelli","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"B431","doi-asserted-by":"publisher","first-page":"e00062","DOI":"10.1016\/j.crwh.2018.e00062","article-title":"Platelet-rich plasma (PRP) for the treatment of vulvar lichen sclerosus in a premenopausal woman: a case report","volume":"18","author":"Franic","year":"2018","journal-title":"Case Rep Womens Health."},{"key":"B432","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.4081\/dr.2024.10079","article-title":"Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study","volume":"17","author":"Tedesco","year":"2025","journal-title":"Dermatol Rep"},{"key":"B433","doi-asserted-by":"publisher","first-page":"e14277","DOI":"10.1111\/dth.14277","article-title":"Adipose tissue stromal vascular fraction and adipose tissue stromal vascular fraction plus platelet-rich plasma grafting: new regenerative perspectives in genital lichen sclerosus","volume":"33","author":"Tedesco","year":"2020","journal-title":"Dermatol Ther."},{"key":"B434","doi-asserted-by":"publisher","first-page":"e70245","DOI":"10.1111\/jocd.70245","article-title":"Efficacy and safety of combined platelet-rich plasma with fractional laser for adult patients with vitiligo: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Feng","year":"2025","journal-title":"J Cosmet Dermatol."},{"key":"B435","doi-asserted-by":"publisher","first-page":"e13444","DOI":"10.1111\/srt.13444","article-title":"The use of platelet-rich plasma in wound healing and vitiligo: a systematic review and meta-analysis","volume":"29","author":"Wang","year":"2023","journal-title":"Skin Res Technol."},{"key":"B436","doi-asserted-by":"publisher","first-page":"34","DOI":"10.25259\/JCAS_16_2024","article-title":"Triple combination of fractional carbon dioxide laser, 308-nm excimer lamp, and platelet-rich plasma in refractory vitiligo: a randomized split-body comparative study","volume":"18","author":"Khalili","year":"2025","journal-title":"J Cutan Aesthet Surg."},{"key":"B437","doi-asserted-by":"publisher","first-page":"e16660","DOI":"10.1111\/jocd.16660","article-title":"A systematic review of case series and clinical trials investigating regenerative medicine for the treatment of vitiligo","volume":"24","author":"Jafarzadeh","year":"2025","journal-title":"J Cosmet Dermatol."},{"key":"B438","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/iwj.13524","article-title":"Current art of combination therapy with autologous platelet-rich plasma for stable vitiligo: a meta-analysis","volume":"18","author":"Chen","year":"2021","journal-title":"Int Wound J."},{"key":"B439","doi-asserted-by":"publisher","first-page":"3000605221119646","DOI":"10.1177\/03000605221119646","article-title":"Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo","volume":"50","author":"Chen","year":"2022","journal-title":"J Int Med Res."},{"key":"B440","doi-asserted-by":"publisher","first-page":"e12944","DOI":"10.1111\/phpp.12944","article-title":"A triple combination of latanoprost, fractional CO laser, and platelet-rich plasma in localized vitiligo: a clinical and histopathologic study","volume":"40","author":"Omar","year":"2024","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"B441","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/DDDT.S239912","article-title":"The usefulness of platelet-rich plasma (PRP) for the treatment of vitiligo: state of the art and review","volume":"14","author":"Mercuri","year":"2020","journal-title":"Drug Des Devel Ther."},{"key":"B442","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2026.02.057","article-title":"Effect of platelet-rich plasma in refractory vitiligo by promoting the differentiation of dermal melanocyte progenitors via IGFBP-2\/RhoA\/YAP pathway","author":"Zhu","year":"2026","journal-title":"J Adv Res."},{"key":"B443","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/ajd.14080","article-title":"The value of adding platelet-rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: a self-controlled randomised double-blinded study","volume":"64","author":"Abdel-Halim","year":"2023","journal-title":"Australas J Dermatol."},{"key":"B444","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/medicina57090904","article-title":"Pilot study on the use of the \u201cMonocyte-Rich\u201d platelet-rich plasma in combination with 1927 nm fractional and 308 nm excimer lasers for the treatment of vitiligo","volume":"57","author":"Mercuri","year":"2021","journal-title":"Medicina"},{"key":"B445","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jdcr.2020.09.021","article-title":"Platelet-rich plasma, a promising adjunctive treatment for vitiligo: a case report","volume":"6","author":"Yin","year":"2020","journal-title":"JAAD Case Rep."},{"key":"B446","doi-asserted-by":"publisher","first-page":"e14738","DOI":"10.1111\/dth.14738","article-title":"Effect of platelet-rich plasma on the outcome of mini-punch grafting procedure in localized stable vitiligo: clinical evaluation and relation to lesional basic fibroblast growth factor","volume":"34","author":"Salem","year":"2021","journal-title":"Dermatol Ther."},{"key":"B447","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1111\/jocd.15050","article-title":"Efficacy of autologous platelet-rich plasma in the treatment of vitiligo: a 10-patient prospective study","volume":"21","author":"Rekik","year":"2022","journal-title":"J Cosmet Dermatol."},{"key":"B448","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jocd.12194","article-title":"The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study","volume":"15","author":"Ibrahim","year":"2016","journal-title":"J Cosmet Dermatol."},{"key":"B449","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s13555-025-01542-8","article-title":"Platelet-rich plasma in the management of alopecia: a systematic review and meta-analysis of clinical evidence","volume":"15","author":"Anitua","year":"2025","journal-title":"Dermatol Ther."},{"key":"B450","doi-asserted-by":"publisher","first-page":"1058431","DOI":"10.3389\/fmed.2022.1058431","article-title":"Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: a systematic review","volume":"9","author":"Tejapira","year":"2022","journal-title":"Front Med."},{"key":"B451","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2147\/DDDT.S356858","article-title":"Platelet rich plasma and its use in hair regrowth: a review","volume":"16","author":"Paichitrojjana","year":"2022","journal-title":"Drug Des Devel Ther."},{"key":"B452","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2450\/2021.0216-2","article-title":"Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis","volume":"21","author":"Cruciani","year":"2023","journal-title":"Blood Transfus."},{"key":"B453","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/09546634.2018.1544405","article-title":"Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata","volume":"30","author":"Rinaldi","year":"2019","journal-title":"J Dermatol Treat."},{"key":"B454","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.jisp.2017.10.002","article-title":"An overview of the biology of platelet-rich plasma and microneedling as potential treatments for alopecia areata","volume":"19","author":"Strazzulla","year":"2018","journal-title":"J Investig Dermatol Symposium Proc."},{"key":"B455","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jaad.2020.12.039","article-title":"Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: a randomized observer-blinded, placebo-controlled, split-head pilot study","volume":"84","author":"Gupta","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B456","doi-asserted-by":"publisher","first-page":"521","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20193223","article-title":"Intralesional triamcinolone acetonide versus platelet rich plasma: a comparative study in the treatment of alopecia areata of scalp","volume":"5","author":"Ranpariya","year":"2019","journal-title":"Int J Res Dermatol."},{"key":"B457","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/JCAS.JCAS_16_19","article-title":"Comparative evaluation of therapeutic efficacy of intralesional injection of triamcinolone acetonide versus intralesional autologous platelet-rich plasma injection in alopecia areata","volume":"13","author":"Kapoor","year":"2020","journal-title":"J Cutan Aesthet Surg."},{"key":"B458","doi-asserted-by":"publisher","first-page":"387","DOI":"10.14744\/SEMB.2025.63444","article-title":"Intralesional platelet-rich plasma injection in patients with recalcitrant alopecia areata","volume":"59","author":"Aydogan","year":"2025","journal-title":"Sisli Etfal Hastanesi Tip Bulteni."},{"key":"B459","doi-asserted-by":"publisher","first-page":"169","DOI":"10.15570\/actaapa.2020.35","article-title":"Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling","volume":"29","author":"Ragab","year":"2020","journal-title":"Acta Dermatovenerologica Alpina, Pannonica, et Adriatica."},{"key":"B460","doi-asserted-by":"publisher","first-page":"e4032","DOI":"10.1097\/GOX.0000000000004032","article-title":"Alopecia areata treated with advanced platelet-rich fibrin using micronization","volume":"10","author":"Vazquez","year":"2022","journal-title":"Plastic Reconstr Surg Glob Open."},{"key":"B461","doi-asserted-by":"publisher","first-page":"e38751","DOI":"10.7759\/cureus.38751","article-title":"Platelet-rich plasma in alopecia areata: a case report with a mini review of literature","volume":"15","author":"Todorova","year":"2023","journal-title":"Cureus."},{"key":"B462","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000534636","article-title":"Growth factors and microneedling in alopecia areata: a narrative review","volume":"10","author":"Almutlq","year":"2024","journal-title":"Skin Append Disord."},{"key":"B463","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/0970-0358.155271","article-title":"Role of platelet-rich plasma in chronic alopecia areata: our centre experience","volume":"48","author":"Singh","year":"2015","journal-title":"Indian J Plast Surg."},{"key":"B464","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jdcr.2021.04.008","article-title":"The role of platelet-rich plasma therapy in refractory folliculitis decalvans","volume":"12","author":"Suh","year":"2021","journal-title":"JAAD Case Rep."},{"key":"B465","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3390\/jcm12062112","article-title":"Platelet-rich plasma and acellular dermal matrix in the surgical treatment of hidradenitis suppurativa: a comparative retrospective study","volume":"12","author":"Gierek","year":"2023","journal-title":"J Clin Med"},{"key":"B466","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/iwj.12117","article-title":"Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix","volume":"12","author":"Nicoli","year":"2015","journal-title":"Int Wound J."},{"key":"B467","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/iwj.12673","article-title":"Accelerated wound healing after wide excisions in hidradenitis suppurativa using autologous split-thickness skin grafting and platelet-rich plasma","volume":"14","author":"Vossen","year":"2017","journal-title":"Int Wound J."},{"key":"B468","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/pde.15979","article-title":"Mini skin graft and platelet-rich fibrin combination following hidradenitis suppurativa surgery: a pediatric case report","volume":"42","author":"Edek","year":"2025","journal-title":"Pediatr Dermatol."},{"key":"B469","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/1534734615598890","article-title":"Hidradenitis suppurativa and wound management","volume":"14","author":"Dini","year":"2015","journal-title":"Int J Low Extrem Wounds."},{"key":"B470","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2450\/BloodTransfus.536","article-title":"Platelet rich plasma use for treatment of acne scars: an overview of systematic reviews","volume":"22","author":"Cruciani","year":"2024","journal-title":"Blood Transfus."},{"key":"B471","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s10103-022-03510-6","article-title":"Clinical evaluation of efficacy of intralesional platelet-rich plasma injection versus 1064 nm long-pulsed Neodymium: YAG laser in the treatment of inflammatory acne vulgaris in adolescent and post-adolescent patients: a prospective randomized split-face comparative study","volume":"37","author":"Moftah","year":"2022","journal-title":"Lasers Med Sci."},{"key":"B472","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00403-022-02511-3","article-title":"Fluid platelet-rich fibrin (PRF) versus platelet-rich plasma (PRP) in the treatment of atrophic acne scars: a comparative study","volume":"315","author":"Diab","year":"2023","journal-title":"Arch Dermatol Res."},{"key":"B473","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1080\/09546634.2020.1793884","article-title":"Platelet rich plasma injection versus topical erythromycin 2% in treatment of acne vulgaris","volume":"33","author":"Ibrahim","year":"2022","journal-title":"J Dermatolog Treat."},{"key":"B474","doi-asserted-by":"publisher","first-page":"55","DOI":"10.29271\/jcpsp.2021.01.55","article-title":"Comparing the efficacy of intra-dermal platelet rich plasma (PRP) versus 50% trichloracetic acid (TCA) using cross technique for atrophic acne scars","volume":"31","author":"Mumtaz","year":"2021","journal-title":"J Coll Phys Surg Pak."},{"key":"B475","doi-asserted-by":"publisher","first-page":"788754","DOI":"10.3389\/fmed.2021.788754","article-title":"Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis","volume":"8","author":"Kang","year":"2021","journal-title":"Front Med."},{"key":"B476","doi-asserted-by":"publisher","first-page":"S1417","DOI":"10.4103\/jpbs.jpbs_804_23","article-title":"Microneedling with PRP for acne scars: a new tool in dermatologist arsenal - a scoping review","volume":"16","author":"Meghe","year":"2024","journal-title":"J Pharm Bioallied Sci."},{"key":"B477","doi-asserted-by":"publisher","first-page":"e15888","DOI":"10.1111\/dth.15888","article-title":"Ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma in the treatment of atrophic acne scars: a systematic review and meta-analysis","volume":"35","author":"Aljefri","year":"2022","journal-title":"Dermatol Ther."},{"key":"B478","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10103-024-04192-y","article-title":"Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarring","volume":"39","author":"Gaumond","year":"2024","journal-title":"Lasers Med Sci."},{"key":"B479","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00266-025-05359-w","article-title":"Evaluation of the efficacy, safety, and satisfaction rates of platelet-rich plasma, non-cross-linked hyaluronic acid, and their combination in patients with acne scars treated with fractional CO laser: a randomized, double-blind, split-face comparative study","volume":"50","author":"Roohaninasab","year":"2026","journal-title":"Aesthetic Plast Surg."},{"key":"B480","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4103\/JCAS.JCAS_160_21","article-title":"Therapeutic efficacy of a plasma rich in growth factors gel combined with fractional ablative laser in the management of post-acne scars","volume":"15","author":"Alegre","year":"2022","journal-title":"J Cutan Aesthet Surg."},{"key":"B481","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/term.3338","article-title":"Platelet-rich plasma in the treatment of scars, to suggest or not to suggest? A systematic review and meta-analysis","volume":"16","author":"Ebrahimi","year":"2022","journal-title":"J Tissue Eng Regen Med."},{"key":"B482","doi-asserted-by":"publisher","first-page":"e15049","DOI":"10.1111\/dth.15049","article-title":"Evaluation of the efficacy and safety of platelet rich plasma injection in treatment of rosacea","volume":"34","author":"Ghoz","year":"2021","journal-title":"Dermatol Ther."},{"key":"B483","doi-asserted-by":"publisher","first-page":"125","DOI":"10.25056\/JCM.2019.3.2.125","article-title":"Improvement of rosacea by injection of platelet-rich plasma","volume":"3","author":"Hwang","year":"2019","journal-title":"J Cosmet Med."},{"key":"B484","doi-asserted-by":"publisher","first-page":"e70031","DOI":"10.1111\/jocd.70031","article-title":"Successful treatment of complex and refractory rosacea using platelet-rich plasma injection therapy: case series and review of the literature","volume":"24","author":"Pang","year":"2025","journal-title":"J Cosmet Dermatol."},{"key":"B485","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.2147\/JPR.S548797","article-title":"Efficacy and safety of pulsed radiofrequency combined with platelet-rich plasma in the treatment of postherpetic neuralgia: a systematic review and meta-analysis","volume":"18","author":"Lu","year":"2025","journal-title":"J Pain Res."},{"key":"B486","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12871-025-03426-y","article-title":"The effects of platelet-rich plasma on zoster-associated pain: a scoping review","volume":"26","author":"Kan HM Ni","year":"2025","journal-title":"BMC Anesthesiol."},{"key":"B487","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1111\/jocd.13864","article-title":"The use of biostatic human amnion and platelet-rich plasma in topical treatment of toxic epidermal necrolysis-a case report","volume":"20","author":"Klama-Bary\u0142a","year":"2021","journal-title":"J Cosmet Dermatol."},{"key":"B488","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/medicina59061114","article-title":"Adult-onset linear morphea (en coupe de sabre) of the face successfully treated with photoactivated low-temperature platelet-rich plasma: a valid therapeutic option","volume":"59","author":"Mercuri","year":"2023","journal-title":"Medicina"},{"key":"B489","first-page":"40","article-title":"Morphea patients treated with platelet rich plasma: a pilot study","volume":"28","author":"Ibrahim","year":"2022","journal-title":"Zagazig Univ Med J"},{"key":"B490","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/wrr.12363","article-title":"Platelet-rich plasma for resistant oral erosions of pemphigus vulgaris: a pilot study","volume":"23","author":"EL-Komy","year":"2015","journal-title":"Wound Repair Regen"},{"key":"B491","doi-asserted-by":"publisher","first-page":"442","DOI":"10.18231\/j.ijced.2024.077","article-title":"Role of intralesional platelet-rich plasma (PRP) therapy in the treatment of recalcitrant oral ulcers of pemphigus vulgaris","volume":"10","author":"Tiwary","year":"2024","journal-title":"IP Indian J Clin Exp Dermatol."},{"key":"B492","doi-asserted-by":"publisher","first-page":"397","DOI":"10.23736\/S2784-8671.20.06664-X","article-title":"Recalcitrant oral involvement in pemphigus vulgaris successfully treated with platelet-rich plasma","volume":"156","author":"Bardazzi","year":"2020","journal-title":"Ital J Dermatol Venereol."},{"key":"B493","doi-asserted-by":"publisher","first-page":"55","DOI":"10.23736\/S2784-8671.23.07696-X","article-title":"Topical applications of heterologous platelet rich plasma (PRP) for refractory gingival lesions in autoimmune blistering diseases","volume":"159","author":"Gabusi","year":"2024","journal-title":"Ital J Dermatol Venerol"},{"key":"B494","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/dj9110137","article-title":"Oral pemphigoid recalcitrant lesion treated with PRGF infiltration. Case report","volume":"9","author":"Anitua","year":"2021","journal-title":"Dent J"},{"key":"B495","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.37275\/bsm.v6i12.625","article-title":"Y FY, S D. Application of topical autologous platelet-rich plasma for treatment of pemphigus foliaceus wounds: a case report bioscientia medicina","volume":"6","author":"Nopriyati","year":"2022","journal-title":"J Biomed Transl Res"},{"key":"B496","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00403-018-1824-x","article-title":"Autologous platelet-rich plasma and triamcinolone acetonide intralesional injection in the treatment of oral erosions of pemphigus vulgaris: a pilot study","volume":"310","author":"El-Komy","year":"2018","journal-title":"Arch Dermatol Res."},{"key":"B497","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/JPDS.JPDS_33_24","article-title":"Adjunct treatment with platelet-rich plasma for the treatment of inflammatory alopecia in an adult filipino female with systemic lupus erythematosus","volume":"33","author":"Imam","year":"2024","journal-title":"J Philippine Dermatol Soc."},{"key":"B498","doi-asserted-by":"publisher","first-page":"309","DOI":"10.36849\/JDD.5933","article-title":"Platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus","volume":"21","author":"Polster","year":"2022","journal-title":"J Drugs Dermatol."},{"key":"B499","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/ijt.ijt_116_21","article-title":"Halting the progression of cicatricial alopecia with injectable platelet-rich fibrin","volume":"15","author":"Chikhalkar","year":"2023","journal-title":"Int J Trichology."},{"key":"B500","doi-asserted-by":"publisher","first-page":"117507","DOI":"10.1016\/j.biopha.2024.117507","article-title":"Effectiveness of platelet derivatives in neuropathic pain management: a systematic review","volume":"180","author":"Anitua","year":"2024","journal-title":"Biomed Pharmacother."},{"key":"B501","doi-asserted-by":"publisher","first-page":"e0250007","DOI":"10.1371\/journal.pone.0250007","article-title":"Reporting in clinical studies on platelet-rich plasma therapy among all medical specialties: a systematic review of Level I and II studies","volume":"16","author":"Nazaroff","year":"2021","journal-title":"PLoS ONE."},{"key":"B502","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/labmed3010008","article-title":"Standardization of platelet-rich plasma preparation in orthopedics: a review of the literature and proposal for a reproducible protocol","volume":"3","author":"Berdini","year":"2026","journal-title":"LabMed."},{"key":"B503","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.20944\/preprints202010.0069.v1","article-title":"Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B504","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12178-018-9527-7","article-title":"Current clinical recommendations for use of platelet-rich plasma","volume":"11","author":"Le","year":"2018","journal-title":"Curr Rev Musculoskelet Med."},{"key":"B505","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.clae.2023.102091","article-title":"Platelet-rich plasma for treating dry eye disease - a systematic review and meta-analysis","volume":"47","author":"Kwaku Akowuah","year":"2024","journal-title":"Contact Lens Anterior Eye."},{"key":"B506","doi-asserted-by":"publisher","first-page":"1500160","DOI":"10.3389\/fmed.2024.1500160","article-title":"Blood component therapy for dry eye disease: a systematic review and network meta-analysis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Med."},{"key":"B507","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.2147\/OPTH.S391536","article-title":"Effect of autologous platelet-rich plasma drops in the treatment of ocular surface disease","volume":"16","author":"Nadelmann","year":"2022","journal-title":"Clin Ophthalmol."},{"key":"B508","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000549202","article-title":"Platelet-rich plasma and combination therapies for dry eye disease: current advances and future directions","volume":"53","author":"Liu","year":"2026","journal-title":"Transfus Med Hemother."},{"key":"B509","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/cells14060458","article-title":"A comprehensive exploration of the biological effects of adipose-derived stem cells in the treatment of systemic sclerosis","volume":"14","author":"Storti","year":"2025","journal-title":"Cells"},{"key":"B510","doi-asserted-by":"publisher","first-page":"101891","DOI":"10.4252\/wjsc.v17.i4.101891","article-title":"Evaluating the efficacy of stem cells in treating severe dry eye disease","volume":"17","author":"Fu","year":"2025","journal-title":"World J Stem Cells."},{"key":"B511","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/life14101268","article-title":"Umbilical cord blood platelet lysate eyedrops for the treatment of severe ocular surface disorders in graft vs. host disease patients: clinical study","volume":"14","author":"Gagliano","year":"2024","journal-title":"Life"},{"key":"B512","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/life15111785","article-title":"Platelets in dry eye disease: a narrative review of biological mechanisms and therapeutic applications derived from platelets","volume":"15","author":"Zeppieri","year":"2025","journal-title":"Life"},{"key":"B513","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/medicina60111764","article-title":"Umbilical cord blood-derived products in autoimmune systemic syndromes with severe dryness: a pilot study","volume":"60","author":"Foti","year":"2024","journal-title":"Medicina"},{"key":"B514","doi-asserted-by":"publisher","first-page":"647012","DOI":"10.3389\/fcell.2021.647012","article-title":"Sanabria-de la Torre R, S\u00e1nchez-D\u00edaz M, Sierra-S\u00e1nchez \u00c1, Montero-V\u00edlchez T, Fern\u00e1ndez-Gonz\u00e1lez A, et al","volume":"9","author":"Qui\u00f1ones-Vico","year":"2021"},{"key":"B515","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/ijd.17982","article-title":"MSC-derived secretome and exosomes in dermatology: mechanisms, therapeutic opportunities, and scientific challenges\u2014a narrative review","volume":"65","author":"da Costa Pereira Cestari","year":"2026","journal-title":"Int J Dermatol."},{"key":"B516","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12015-024-10835-y","article-title":"Elevating dermatology beyond aesthetics: perinatal-derived advancements for rejuvenation, alopecia strategies, scar therapies, and progressive wound healing","volume":"21","author":"Khalilzad","year":"2025","journal-title":"Stem Cell Rev Rep."},{"key":"B517","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/stcltm\/szad017","article-title":"Expert consideration on regulatory aspects for perinatal derivatives in clinical settings","volume":"12","author":"Hofmann","year":"2023","journal-title":"Stem Cells Transl Med."},{"key":"B518","doi-asserted-by":"publisher","first-page":"598816","DOI":"10.3389\/fcell.2020.598816","article-title":"Technical procedures for preparation and administration of platelet-rich plasma and related products: a scoping review","volume":"8","author":"Pachito","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B519","doi-asserted-by":"publisher","first-page":"3","DOI":"10.11138\/mltj\/2014.4.1.0013","article-title":"Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives","volume":"4","author":"Dohan Ehrenfest","year":"2014","journal-title":"Muscles Ligaments Tendons J."},{"key":"B520","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0363546517746112","article-title":"Huis In 't Veld R, Vochteloo AJH. Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature","volume":"47","author":"Oudelaar","year":"2019","journal-title":"Am J Sports Med"},{"key":"B521","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11420-016-9519-3","article-title":"Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition","volume":"13","author":"Degen","year":"2017","journal-title":"HSS J."},{"key":"B522","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/prd.12626","article-title":"Platelet-rich plasma (PRP) versus injectable platelet-rich fibrin (i-PRF): a systematic review across all fields of medicine","volume":"99","author":"Farshidfar","year":"2025","journal-title":"Periodontology"},{"key":"B523","doi-asserted-by":"publisher","first-page":"23259671211011948","DOI":"10.1177\/23259671211011948","article-title":"Adverse reactions and clinical outcomes for leukocyte-poor versus leukocyte-rich platelet-rich plasma in knee osteoarthritis: a systematic review and meta-analysis","volume":"9","author":"Kim","year":"2021","journal-title":"Orthopaed J Sports Med."},{"key":"B524","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4103\/idoj.idoj_86_24","article-title":"Possible role of platelet-rich plasma in the treatment of patients with postherpetic neuralgia: a prospective, single-arm, open-label clinical study","volume":"15","author":"Abu El-Hamd","year":"2024","journal-title":"Indian Dermatol Online J."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1901254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:28:47Z","timestamp":1789720127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1901254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":524,"alternative-id":["10.3389\/fmed.2026.1901254"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1901254","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1901254"}}